<html class="gs_el_sm gs_pfcs"><head><title>‪Janet Dunn‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=ty1gkewAAAAJ&amp;hl=en"><meta name="description" content="‪University of Warwick‬ - ‪‪Cited by 27,456‬‬ - ‪clinical trials‬ - ‪oncology‬ - ‪statistics‬"><meta property="og:description" content="‪University of Warwick‬ - ‪‪Cited by 27,456‬‬ - ‪clinical trials‬ - ‪oncology‬ - ‪statistics‬"><meta property="og:title" content="Janet Dunn"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"geA0YZejLoX0mgGEgoSgBQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=ty1gkewAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTYyAYBEFHXXfJp6FPbSpuzmUIY_EIvX"><input type="hidden" name="user" value="ty1gkewAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">27456</td><td class="gsc_rsb_std">12402</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">61</td><td class="gsc_rsb_std">42</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">166</td><td class="gsc_rsb_std">113</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:934px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:888px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">2800</div><div class="gsc_g_xtl" style="top:73px;">1400</div><div class="gsc_g_xtl" style="top:113px;">700</div><div class="gsc_g_xtl" style="top:33px;">2100</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:156px;height:4px;z-index:27"><span class="gsc_g_al">80</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:155px;height:5px;z-index:26"><span class="gsc_g_al">104</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:155px;height:5px;z-index:25"><span class="gsc_g_al">91</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:151px;height:9px;z-index:24"><span class="gsc_g_al">158</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:149px;height:11px;z-index:23"><span class="gsc_g_al">196</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:143px;height:17px;z-index:22"><span class="gsc_g_al">301</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:140px;height:20px;z-index:21"><span class="gsc_g_al">365</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:137px;height:23px;z-index:20"><span class="gsc_g_al">417</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:133px;height:27px;z-index:19"><span class="gsc_g_al">478</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:125px;height:35px;z-index:18"><span class="gsc_g_al">617</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:120px;height:40px;z-index:17"><span class="gsc_g_al">714</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:115px;height:45px;z-index:16"><span class="gsc_g_al">795</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:107px;height:53px;z-index:15"><span class="gsc_g_al">941</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:103px;height:57px;z-index:14"><span class="gsc_g_al">998</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:106px;height:54px;z-index:13"><span class="gsc_g_al">962</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:101px;height:59px;z-index:12"><span class="gsc_g_al">1039</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:94px;height:66px;z-index:11"><span class="gsc_g_al">1166</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:92px;height:68px;z-index:10"><span class="gsc_g_al">1207</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:93px;height:67px;z-index:9"><span class="gsc_g_al">1183</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:88px;height:72px;z-index:8"><span class="gsc_g_al">1269</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:82px;height:78px;z-index:7"><span class="gsc_g_al">1365</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:72px;height:88px;z-index:6"><span class="gsc_g_al">1544</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:63px;height:97px;z-index:5"><span class="gsc_g_al">1711</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:49px;height:111px;z-index:4"><span class="gsc_g_al">1956</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:28px;height:132px;z-index:3"><span class="gsc_g_al">2323</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:3px;height:157px;z-index:2"><span class="gsc_g_al">2762</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:45px;height:115px;z-index:1"><span class="gsc_g_al">2017</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=ty1gkewAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dty1gkewAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>82 articles</span></div><div class="gsc_rsb_m_na"><div>6 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:7%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="Janet Dunn" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Janet Dunn</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=7480735251086199542" class="gsc_prf_ila">University of Warwick</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at warwick.ac.uk - <a href="http://www2.warwick.ac.uk/fac/med/staff/dunn" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:clinical_trials" class="gsc_prf_inta gs_ibl">clinical trials</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:oncology" class="gsc_prf_inta gs_ibl">oncology</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:statistics" class="gsc_prf_inta gs_ibl">statistics</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTYyAYBEFHXXfJp6FPbSpuzmUIY_EIvX"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=ty1gkewAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials</a><div class="gs_gray">Early Breast Cancer Trialists' Collaborative Group</div><div class="gs_gray">The Lancet 366 (9503), 2087-2106<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16353664352333716337" class="gsc_a_ac gs_ibl">5174</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer</a><div class="gs_gray">JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ...</div><div class="gs_gray">New England Journal of Medicine 350 (12), 1200-1210<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15687344652969873160" class="gsc_a_ac gs_ibl">2822</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Polychemotherapy for early breast cancer: an overview of the randomised trials</a><div class="gs_gray">Early Breast Cancer Trialists' Collaborative Group</div><div class="gs_gray">The Lancet 352 (9132), 930-942<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=300292557512793759" class="gsc_a_ac gs_ibl">1874</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer</a><div class="gs_gray">JA Witjes, T Lebret, EM Compérat, NC Cowan, M De Santis, HM Bruins, ...</div><div class="gs_gray">European urology 71 (3), 462-475<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10356569902210906987,9272924550891857846,7174705864587366111,1482854250376136800" class="gsc_a_ac gs_ibl">1289</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial</a><div class="gs_gray">JP Neoptolemos, JA Dunn, DD Stocken, J Almond, K Link, H Beger, ...</div><div class="gs_gray">The Lancet 358 (9293), 1576-1585<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14647324753392910217" class="gsc_a_ac gs_ibl">1152</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer</a><div class="gs_gray">D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, ...</div><div class="gs_gray">Journal of Clinical Oncology 27 (33), 5513-5518<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5483614287705466946" class="gsc_a_ac gs_ibl">878</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D).</a><div class="gs_gray">AM Young, A Marshall, J Thirlwall, O Chapman, A Lokare, C Hill, D Hale, ...</div><div class="gs_gray">J Clin Oncol<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8604036006704305499" class="gsc_a_ac gs_ibl">717</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial</a><div class="gs_gray">JP Neoptolemos, DD Stocken, JA Dunn, J Almond, HG Beger, P Pederzoli, ...</div><div class="gs_gray">Annals of surgery 234 (6), 758<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4057752008536735311" class="gsc_a_ac gs_ibl">664</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Phase 2 of CATALISE: A multinational and multidisciplinary Delphi consensus study of problems with language development: Terminology</a><div class="gs_gray">DVM Bishop, MJ Snowling, PA Thompson, T Greenhalgh, ...</div><div class="gs_gray">Journal of Child Psychology and Psychiatry 58 (10), 1068-1080<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15362656928704556155" class="gsc_a_ac gs_ibl">622</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients</a><div class="gs_gray">HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...</div><div class="gs_gray">Annals of oncology 25 (8), 1536-1543<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10625334092187737559" class="gsc_a_ac gs_ibl">528</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial</a><div class="gs_gray">HER Ford, A Marshall, JA Bridgewater, T Janowitz, FY Coxon, J Wadsley, ...</div><div class="gs_gray">The lancet oncology 15 (1), 78-86<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9512261844163277008" class="gsc_a_ac gs_ibl">515</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical&nbsp;…</a><div class="gs_gray">BM Augustson, G Begum, JA Dunn, NJ Barth, F Davies, G Morgan, ...</div><div class="gs_gray">Journal of clinical oncology 23 (36), 9219-9226<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5308194994572104503" class="gsc_a_ac gs_ibl">442</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial</a><div class="gs_gray">H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...</div><div class="gs_gray">The Lancet 393 (10166), 51-60<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10293218906308726943" class="gsc_a_ac gs_ibl">440</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">PET-CT surveillance versus neck dissection in advanced head and neck cancer</a><div class="gs_gray">H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...</div><div class="gs_gray">New England Journal of Medicine 374 (15), 1444-1454<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16029157814212285958" class="gsc_a_ac gs_ibl">423</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:qjMakFHDy7sC" class="gsc_a_at">The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up</a><div class="gs_gray">MT Hallissey, JA Dunn, LC Ward, WH Allum, BSC Group</div><div class="gs_gray">The Lancet 343 (8909), 1309-1312<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6787183876263828666" class="gsc_a_ac gs_ibl">409</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults.</a><div class="gs_gray">EV McCloskey, IC MacLennan, MT Drayson, C Chapman, J Dunn, ...</div><div class="gs_gray">British journal of haematology 100 (2), 317-325<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11549222610574029881" class="gsc_a_ac gs_ibl">376</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Cigarette Smoking and pancreas cancer: a case—control study based on direct interviews</a><div class="gs_gray">DT Silverman, JA Dunn, RN Hoover, M Schiffiman, KD Lillemoe, ...</div><div class="gs_gray">JNCI: Journal of the National Cancer Institute 86 (20), 1510-1516<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11146867116518949437" class="gsc_a_ac gs_ibl">367</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer</a><div class="gs_gray">CJ Poole, HM Earl, L Hiller, JA Dunn, S Bathers, RJ Grieve, DA Spooner, ...</div><div class="gs_gray">New England Journal of Medicine 355 (18), 1851-1862<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10476858831429370489" class="gsc_a_ac gs_ibl">227</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Tamoxifen for early breast cancer: an overview of the randomised trials</a><div class="gs_gray">O Abe, R Abe, KT Enomoto, K Kikuchi, H Koyama, Y Nomura, K Sakai, ...</div><div class="gs_gray">The Lancet 351 (9114), 1451-1467<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13463396796076415663,3230232121454497995" class="gsc_a_ac gs_ibl">224</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;citation_for_view=ty1gkewAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes</a><div class="gs_gray">HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ...</div><div class="gs_gray">Annals of Oncology 26 (7), 1488-1493<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8194359637500529962" class="gsc_a_ac gs_ibl">220</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Neo‐adjuvant (pre‐emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder</a><div class="gs_gray">DMA Wallace, D Raghavan, KA Kelly, TF Sandeman, IG Conn, N Teriana, ...</div><div class="gs_gray">British journal of urology 67 (6), 608-615<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5910134088982543923" class="gsc_a_ac gs_ibl">217</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Long‐term follow‐up of a prospective, double‐blind, placebo‐controlled randomized trial of clodronate in multiple myeloma</a><div class="gs_gray">EV McCloskey, JA Dunn, JA Kanis, ICM MacLennan, MT Drayson, ...</div><div class="gs_gray">British journal of haematology 113 (4), 1035-1043<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11264493406960272435" class="gsc_a_ac gs_ibl">207</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases</a><div class="gs_gray">TJ Priestman, J Dunn, M Brada, R Rampling, PG Baker</div><div class="gs_gray">Clinical oncology 8 (5), 308-315<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=53389807255231635" class="gsc_a_ac gs_ibl">190</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Adjuvant therapy in pancreatic cancer: historical and current perspectives</a><div class="gs_gray">JP Neoptolemos, D Cunningham, H Friess, C Bassi, DD Stocken, DM Tait, ...</div><div class="gs_gray">Annals of oncology 14 (5), 675-692<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3014437511088456631" class="gsc_a_ac gs_ibl">181</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis</a><div class="gs_gray">ICM MacLennan, C Chapman, JA Dunn, K Kelly, FTMRC Working</div><div class="gs_gray">The Lancet 339 (8787), 200-205<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15455282341162403603" class="gsc_a_ac gs_ibl">167</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer</a><div class="gs_gray">DJ Kerr, JA Dunn, MJ Langman, JL Smith, RSJ Midgley, A Stanley, ...</div><div class="gs_gray">New England Journal of Medicine 357 (4), 360-369<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4946546346411785152" class="gsc_a_ac gs_ibl">155</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Delay and survival in bladder cancer</a><div class="gs_gray">DMA Wallace, RT Bryan, JA Dunn, G Begum, S Bathers, ...</div><div class="gs_gray">BJU international 89 (9), 868-878<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10748041061669433141" class="gsc_a_ac gs_ibl">152</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">Elevated CO2-induced responses in stomata require ABA and ABA signaling</a><div class="gs_gray">C Chater, K Peng, M Movahedi, JA Dunn, HJ Walker, YK Liang, ...</div><div class="gs_gray">Current Biology 25 (20), 2709-2716<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11163172424577908128" class="gsc_a_ac gs_ibl">151</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine&nbsp;…</a><div class="gs_gray">KS Olah, JA Dunn, H Gee</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 99 (7), 590-594<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11509841926598175666" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial</a><div class="gs_gray">HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...</div><div class="gs_gray">The Lancet 393 (10191), 2599-2612<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10121998469098993826" class="gsc_a_ac gs_ibl">146</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)</a><div class="gs_gray">JMS Bartlett, AF Munro, JA Dunn, C McConkey, S Jordan, CJ Twelves, ...</div><div class="gs_gray">The lancet oncology 11 (3), 266-274<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8628907002871276613" class="gsc_a_ac gs_ibl">139</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Comparing breast cancer multiparameter tests in the OPTIMA prelim trial: no test is more equal than the others</a><div class="gs_gray">J Bartlett, J Bayani, A Marshall, JA Dunn, A Campbell, C Cunningham, ...</div><div class="gs_gray">JNCI: Journal of the National Cancer Institute 108 (9)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8333535167714281067" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Retrospective analysis of 318 cases of uterine sarcoma</a><div class="gs_gray">KS Olah, H Gee, S Blunt, JA Dunn, K Kelly, KK Chan</div><div class="gs_gray">European Journal of Cancer and Clinical Oncology 27 (9), 1095-1099<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11213143256530950614" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer</a><div class="gs_gray">D Cunningham</div><div class="gs_gray">Eur J Cancer Supplements 3, PS11<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1398070463600355573" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease</a><div class="gs_gray">SR Bramhall, GWH Stamp, J Dunn, NR Lemoine, JP Neoptolemos</div><div class="gs_gray">British journal of cancer 73 (8), 972-978<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10789754863068066946" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials</a><div class="gs_gray">S Pasquali, JD Maqueo, J Vela, RA Kyle, T Leong, E Fritz, S Suciu, ...</div><div class="gs_gray">Journal of Clinical Oncology 16 (12)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9677996194443332922" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early&nbsp;…</a><div class="gs_gray">HM Earl, AL Vallier, L Hiller, N Fenwick, J Young, M Iddawela, J Abraham, ...</div><div class="gs_gray">The lancet oncology 15 (2), 201-212<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3703070866216478717" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, JA Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...</div><div class="gs_gray">The lancet oncology 16 (6), 656-666<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11555968229777439346" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical&nbsp;…</a><div class="gs_gray">M Drayson, G Begum, S Basu, S Makkuni, J Dunn, N Barth, JA Child</div><div class="gs_gray">Blood 108 (6), 2013-2019<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3863591411078367769" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Pregnancy outcome after large loop excision of the cervical transformation zone</a><div class="gs_gray">PI Blomfield, J Buxton, J Dunn, DM Luesley</div><div class="gs_gray">American journal of obstetrics and gynecology 169 (3), 620-625<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7871757861909635548" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Phase III randomized comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer</a><div class="gs_gray">D Cunningham</div><div class="gs_gray">Eur J cancer 3<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3880690740906656093" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five‐year cancer registry review</a><div class="gs_gray">CB FINN, DM Luesley, EJ Buxton, GR Blackledge, K Kelly, JA Dunn, ...</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 99 (1), 54-58<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3435600722585062437" class="gsc_a_ac gs_ibl">98</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study</a><div class="gs_gray">PG Corrie, A Marshall, JA Dunn, MR Middleton, PD Nathan, M Gore, ...</div><div class="gs_gray">The Lancet Oncology 15 (6), 620-630<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3357067035040790011" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:mB3voiENLucC" class="gsc_a_at">Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel</a><div class="gs_gray">JE Abraham, Q Guo, L Dorling, J Tyrer, S Ingle, R Hardy, AL Vallier, ...</div><div class="gs_gray">Clinical Cancer Research 20 (9), 2466-2475<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1620043060325241812" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial</a><div class="gs_gray">RS Midgley, CC McConkey, EC Johnstone, JA Dunn, JL Smith, ...</div><div class="gs_gray">Journal of clinical oncology 28 (30), 4575-4580<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14041692171678519751" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities</a><div class="gs_gray">MI Shafi, DM Luesley, JA Jordan, JA Dunn, TP Rollason, M Yates</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 104 (5), 590-594<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15587967943129375334" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:lSLTfruPkqcC" class="gsc_a_at">A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease</a><div class="gs_gray">RA Scott, DF Freitag, L Li, AY Chu, P Surendran, R Young, N Grarup, ...</div><div class="gs_gray">Science translational medicine 8 (341), 341ra76-341ra76<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5064364217304405332" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:M7yex6snE4oC" class="gsc_a_at">Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma</a><div class="gs_gray">RJ Lee, G Gremel, A Marshall, KA Myers, N Fisher, JA Dunn, N Dhomen, ...</div><div class="gs_gray">Annals of Oncology 29 (2), 490-496<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8207349790303615724" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-α) in metastatic melanoma</a><div class="gs_gray">AM Young, J Marsden, A Goodman, A Burton, JA Dunn</div><div class="gs_gray">Clinical Oncology 13 (6), 458-465<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11717102870628072088" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:PaBasH6fAo0C" class="gsc_a_at">PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, AL Vallier, S Loi, D Howe, HB Higgins, K McAdam, ...</div><div class="gs_gray">Journal of Clinical Oncology 36 (15_suppl), 506-506<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5730155664559980507" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Observer variability among colposcopists from the West Midlands region</a><div class="gs_gray">IJ Etherington, DM Luesley, MI Shafi, J Dunn, L Hiller, JA Jordan</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 104 (12), 1380-1384<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6020130229360364287" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer</a><div class="gs_gray">CCW Yu, DA Levison, JA Dunn, LC Ward, M Demonakou, WH Allum, ...</div><div class="gs_gray">British journal of cancer 71 (5), 1106-1110<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14345780859200122916" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Pathogenesis of gall stones in Crohn's disease: an alternative explanation.</a><div class="gs_gray">R Hutchinson, PN Tyrrell, D Kumar, JA Dunn, JK Li, RN Allan</div><div class="gs_gray">Gut 35 (1), 94-97<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12552190170046187534" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform</a><div class="gs_gray">S Treweek, DG Altman, P Bower, M Campbell, I Chalmers, S Cotton, ...</div><div class="gs_gray">Trials 16 (1), 1-10<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7409704257068437026" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Factors influencing blood transfusion during adult liver transplantation.</a><div class="gs_gray">M Deakin, BK Gunson, JA Dunn, P McMaster, G Tisone, J Warwick, ...</div><div class="gs_gray">Annals of The Royal College of Surgeons of England 75 (5), 339<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17878729638534957261" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Prognostic factors in acute renal failure following aortic aneurysm surgery</a><div class="gs_gray">F Berisa, M Beaman, D Adu, RJS McGonigle, J Michael, R Downing, ...</div><div class="gs_gray">QJM: An International Journal of Medicine 76 (1), 689-698<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15862753620828419385" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:maZDTaKrznsC" class="gsc_a_at">The value of source data verification in a cancer clinical trial</a><div class="gs_gray">C Tudur Smith, DD Stocken, J Dunn, T Cox, P Ghaneh, D Cunningham, ...</div><div class="gs_gray">PloS one 7 (12), e51623<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=307751418168037038" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial</a><div class="gs_gray">C Bassi, DD Stocken, A Olah, H Friess, J Buckels, H Hickey, C Dervenis, ...</div><div class="gs_gray">Digestive surgery 22 (5), 353-363<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1011287374285497655" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery</a><div class="gs_gray">A Bradley, A Marshall, L Stonehewer, L Reaper, K Parker, E Bevan-Smith, ...</div><div class="gs_gray">European Journal of Cardio-Thoracic Surgery 44 (4), e266-e271<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5877438957811756668" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Resection-line involvement in gastric cancer: a continuing problem</a><div class="gs_gray">MT Hallissey, AJ Jewkes, JA Dunn, L Ward, JWL Fielding</div><div class="gs_gray">Journal of British Surgery 80 (11), 1418-1420<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17319405473325300540" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">NEAT (National Epirubicin Adjuvant Trial) and SCTBG BR9601 (Scottish Cancer Trials Breast Group) phase III adjuvant breast trials show a survival advantage for sequential ECMF.</a><div class="gs_gray">CJ Poole, HM Earl, JA Dunn, L Hiller, S Bathers, D Spooner, RJ Grieve, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S9-S9<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14320979677033455021" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">The quality of life of early breast cancer patients treated by two different radiotherapy regimens</a><div class="gs_gray">LM Wallace, SG Priestman, JA Dunn, TJ Priestman</div><div class="gs_gray">Clinical Oncology 5 (4), 228-233<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4136788177949226882" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:SP6oXDckpogC" class="gsc_a_at">OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.</a><div class="gs_gray">RC Stein, JA Dunn, JMS Bartlett, AF Campbell, A Marshall, P Hall, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 20 (10), 1<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=800961109662307807" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:4DMP91E08xMC" class="gsc_a_at">Digital imaging colposcopy, image analysis and quantification of the colposcopic image</a><div class="gs_gray">MI Shafi, JA Dunn, R Chenoy, EJ Buxton, C Williams, DM Luesley</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 101 (3), 234-238<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9880880761249352953" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:dhFuZR0502QC" class="gsc_a_at">Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer</a><div class="gs_gray">B Waymont, TH Lynch, JA Dunn, LA Emtage, DG Arkell, DMA Wallace, ...</div><div class="gs_gray">British journal of urology 69 (6), 614-620<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8732315395560509722" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Predicting anthracycline benefit: TOP2A and CEP17-not only but also</a><div class="gs_gray">JM Bartlett, CC McConkey, AF Munro, C Desmedt, JA Dunn, ...</div><div class="gs_gray">J Clin Oncol 33 (15), 1680-1687<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6498785493999573085" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism: results of the Select-D™ pilot trial</a><div class="gs_gray">A Young, A Marshall, J Thirlwall, C Hill, D Hale, J Dunn, A Lokare, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 625-625<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12426903227254089055" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Identification of novel genetic markers of breast cancer survival</a><div class="gs_gray">Q Guo, MK Schmidt, P Kraft, S Canisius, C Chen, S Khan, J Tyrer, ...</div><div class="gs_gray">Journal of the National Cancer Institute 107 (5), djv081<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9646484256366869563" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:ODE9OILHJdcC" class="gsc_a_at">PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned&nbsp;…</a><div class="gs_gray">H Mehanna, CC McConkey, JK Rahman, WL Wong, AF Smith, C Nutting, ...</div><div class="gs_gray">National Institute for Health Research<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15677735566226838938" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data</a><div class="gs_gray">T Janowitz, P Thuss-Patience, A Marshall, JH Kang, C Connell, N Cook, ...</div><div class="gs_gray">British journal of cancer 114 (4), 381-387<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2782604192425752226" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Soluble syndecan‐1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival</a><div class="gs_gray">R Lovell, JA Dunn, G Begum, NJ Barth, T Plant, PA Moss, MT Drayson, ...</div><div class="gs_gray">British journal of haematology 130 (4), 542-548<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=63139043724627752" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Cigarette smoking and histological outcome in wom with mildly dyskaryotic cervical smears</a><div class="gs_gray">D Luesley, P Blomfield, J Dunn, M Shafi, R Chenoy, J Buxton</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 101 (1), 49-52<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3976207317551994433" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial</a><div class="gs_gray">MT Drayson, S Bowcock, T Planche, G Iqbal, G Pratt, K Yong, J Wood, ...</div><div class="gs_gray">The Lancet Oncology 20 (12), 1760-1772<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9703705622581468514" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial</a><div class="gs_gray">J Bartlett, P Canney, A Campbell, D Cameron, J Donovan, J Dunn, H Earl, ...</div><div class="gs_gray">Clinical oncology 25 (2), 109-116<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15335960129562102264" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:-f6ydRqryjwC" class="gsc_a_at">A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in&nbsp;…</a><div class="gs_gray">J Herod, A Burton, J Buxton, J Tobias, D Luesley, S Jordan, J Dunn, ...</div><div class="gs_gray">Annals of oncology 11 (9), 1175-1182<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2250584591559233630" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions</a><div class="gs_gray">MT Hallissey, JA Dunn, JWL Fielding</div><div class="gs_gray">Scandinavian journal of gastroenterology 29 (12), 1129-1134<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6612324202203257474" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer</a><div class="gs_gray">HR Ali, A Dariush, E Provenzano, H Bardwell, JE Abraham, M Iddawela, ...</div><div class="gs_gray">Breast Cancer Research 18 (1), 1-11<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3404932800632751629" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer</a><div class="gs_gray">PW Cooke, JA Dunn, T Latief, S Bathers, ND James, DMA Wallace</div><div class="gs_gray">European urology 38 (3), 279-286<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12991243182823835144" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Rapid diagnostic service for patients with haematuria.</a><div class="gs_gray">TH Lynch, B Waymont, JA Dunn, MA Hughes, DM Wallace</div><div class="gs_gray">British journal of urology 73 (2), 147-151<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=684604212925092971" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:IWHjjKOFINEC" class="gsc_a_at">MRC trial of α2b‐interferon maintenance therapy in first plateau phase of multiple myeloma</a><div class="gs_gray">MT Drayson, CE Chapman, JA Dunn, AB Olujohungbe, ICM MacLennan, ...</div><div class="gs_gray">British journal of haematology 101 (1), 195-202<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13486688623345451643" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Abnormal cervical cytology following large loop excision of the transformation zone: a case controlled study</a><div class="gs_gray">MI Shafi, JA Dunn, EJ Buxton, CB Finn, JA Jordan, DM Luesley</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 100 (2), 145-148<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16818290838870152799" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:HDshCWvjkbEC" class="gsc_a_at">tAnGo: a randomized phase III trial of gemcitabine (gem) in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy (CT) for women with early-stage&nbsp;…</a><div class="gs_gray">CJ Poole, L Hiller, HC Howard, JA Dunn, P Canney, AM Wardley, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 506-506<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15478463021502712135" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:P5F9QuxV20EC" class="gsc_a_at">A ‘new normal’: exploring the disruption of a poor prognostic cancer diagnosis using interviews and participant-produced photographs</a><div class="gs_gray">C Balmer, F Griffiths, J Dunn</div><div class="gs_gray">Health: 19 (5), 451-472<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2282797183566211738" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer</a><div class="gs_gray">PS Stonelake, NJ Bundred, NP Neoptolemos, PR Baker, PG Baker, ...</div><div class="gs_gray">European Journal of Cancer 30 (1), 5-11<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3887036616720927040" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Geographic variation in human papillomavirus–related oropharyngeal cancer: Data from 4 multinational randomized trials</a><div class="gs_gray">H Mehanna, N Franklin, N Compton, M Robinson, N Powell, ...</div><div class="gs_gray">Head &amp; neck 38 (S1), E1863-E1869<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=352484604627488554" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:r0BpntZqJG4C" class="gsc_a_at">COUGAR-02: A randomized phase III study of docetaxel versus active symptom control in advanced esophagogastric adenocarcinoma.</a><div class="gs_gray">H Ford, A Marshall, J Wadsley, FY Coxon, W Mansoor, JA Bridgewater, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (4_suppl), LBA4-LBA4<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7303800006571570043" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Etoposide protein binding in cancer patients</a><div class="gs_gray">B Liu, HM Earl, CJ Poole, J Dunn, DJ Kerr</div><div class="gs_gray">Cancer chemotherapy and pharmacology 36 (6), 506-512<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2495109242196310028" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">Behaviour problems in schools: An evaluation of support centres</a><div class="gs_gray">P Mortimore, J Davies, A Varlaam, A West, P Devine, J Mazza</div><div class="gs_gray">Routledge<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12222298521436821305" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">OC-11-Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism</a><div class="gs_gray">A Young, J Phillips, H Hancocks, C Hill, N Joshi, A Marshall, J Grumett, ...</div><div class="gs_gray">Thrombosis research 140, S172-S173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6673578820594901032,7683848961092225778,967954753132071437" class="gsc_a_ac gs_ibl">39</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="ty1gkewAAAAJ:5Ul4iDaHHb8C">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Thoracoscore fails to predict complications following elective lung resection</a><div class="gs_gray">A Bradley, A Marshall, M Abdelaziz, K Hussain, P Agostini, E Bishay, ...</div><div class="gs_gray">European Respiratory Journal 40 (6), 1496-1501<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9856185121557784565" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients</a><div class="gs_gray">LC Ward, JWL Fielding, JA Dunn, KA Kelly</div><div class="gs_gray">British journal of cancer 66 (5), 943-950<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14786261139865300932" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Lesion size and histology of atypical cervical transformation zone</a><div class="gs_gray">MI Shafi, CB Finn, DM Luesley, JA Jordan, J Dunn</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 98 (5), 490-492<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7902996092717027819" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Common germline polymorphisms associated with breast cancer-specific survival</a><div class="gs_gray">A Pirie, Q Guo, P Kraft, S Canisius, DM Eccles, N Rahman, H Nevanlinna, ...</div><div class="gs_gray">Breast cancer research 17 (1), 1-11<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15342655595746175183" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes–what does it all mean?</a><div class="gs_gray">H Earl, E Provenzano, J Abraham, J Dunn, AL Vallier, I Gounaris, L Hiller</div><div class="gs_gray">BMC medicine 13 (1), 1-11<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7526953495988343807" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:GnPB-g6toBAC" class="gsc_a_at">A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial</a><div class="gs_gray">E Provenzano, AL Vallier, R Champ, K Walland, S Bowden, A Grier, ...</div><div class="gs_gray">British journal of cancer 108 (4), 866-872<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8590364383461302223" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Video colpography: a new technique for secondary cervical screening</a><div class="gs_gray">IJ Etherington, J Dunn, MI Shafi, T Smith, DM Luesley</div><div class="gs_gray">BJOG: An International Journal of Obstetrics &amp; Gynaecology 104 (2), 150-153<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5768777980342871401" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:KaMxkj08jr0C" class="gsc_a_at">Effects of Radiotherapy and Surgery in Early Breast-Cancer-an Overview of the Randomized Trials</a><div class="gs_gray">O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Iino, K Kikuchi, ...</div><div class="gs_gray">New England Journal of Medicine 333 (22), 1444-1455<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12505679983405220107" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial</a><div class="gs_gray">PG Corrie, A Marshall, PD Nathan, P Lorigan, M Gore, S Tahir, G Faust, ...</div><div class="gs_gray">Annals of Oncology 29 (8), 1843-1852<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14817662136722167152" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:BqipwSGYUEgC" class="gsc_a_at">The cost-effectiveness of adjuvant chemotherapy for early breast cancer: a comparison of no chemotherapy and first, second, and third generation regimens for patients with&nbsp;…</a><div class="gs_gray">HE Campbell, D Epstein, D Bloomfield, S Griffin, A Manca, J Yarnold, ...</div><div class="gs_gray">European Journal of Cancer 47 (17), 2517-2530<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7543649586494365681" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=ty1gkewAAAAJ:eAlLMO4JVmQC" class="gsc_a_at">Improvement of an enhanced recovery protocol for radical cystectomy</a><div class="gs_gray">A Koupparis, J Dunn, D Gillatt, E Rowe</div><div class="gs_gray">British Journal of Medical and Surgical Urology 3 (6), 237-240<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13697560486934769692" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review</a><div class="gs_gray">V Hernandez, EL Espinos, J Dunn, S MacLennan, T Lam, Y Yuan, ...</div><div class="gs_gray">Urologic Oncology: Seminars and Original Investigations 35 (9), 539. e17-539&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=506508276749642189" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer</a><div class="gs_gray">MJS Langman, JA Dunn, JL Whiting, A Burton, MT Hallissey, ...</div><div class="gs_gray">British journal of cancer 81 (8), 1356-1362<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5743214568187385696" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation</a><div class="gs_gray">L Rooshenas, LJ Scott, JM Blazeby, CA Rogers, KM Tilling, S Husbands, ...</div><div class="gs_gray">Journal of clinical epidemiology 106, 108-120<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5990688528054192625" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials</a><div class="gs_gray">JLJ Heaney, JP Campbell, G Iqbal, D Cairns, A Richter, JA Child, ...</div><div class="gs_gray">Leukemia 32 (8), 1727-1738<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2745544918784569116" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hMod-77fHWUC" class="gsc_a_at">Options for early breast cancer follow-up in primary and secondary care-a systematic review</a><div class="gs_gray">F Taggart, P Donnelly, J Dunn</div><div class="gs_gray">BMC cancer 12 (1), 1-12<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15136897221777828133" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, JA Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...</div><div class="gs_gray">Annals of Oncology 28 (8), 1817-1824<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7896305068620007795" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Trastuzumab-associated cardiac events in the Persephone trial</a><div class="gs_gray">HM Earl, AL Vallier, J Dunn, S Loi, E Ogburn, K McAdam, ...</div><div class="gs_gray">British journal of cancer 115 (12), 1462-1470<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10512487749348367617" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:yD5IFk8b50cC" class="gsc_a_at">A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years</a><div class="gs_gray">RT Bryan, MP Zeegers, EH van Roekel, D Bird, MR Grant, JA Dunn, ...</div><div class="gs_gray">BJU international 112 (2), 169-175<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13423005701239706581" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">NEAT: National Epirubicin Adjuvant Trial–toxicity, delivered dose intensity and quality of life</a><div class="gs_gray">HM Earl, L Hiller, JA Dunn, S Bathers, P Harvey, A Stanley, RJ Grieve, ...</div><div class="gs_gray">British journal of cancer 99 (8), 1226-1231<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17860630686858613476" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas.</a><div class="gs_gray">DB Evans, KR Hess, PW Pisters</div><div class="gs_gray">Annals of surgery 236 (5), 694; author reply 694-6<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16406845077569078916,3026666885402466188,4127350099639068560" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Repeat testing for haematuria and underlying urological pathology</a><div class="gs_gray">TH Lynch, B Waymont, JA Dunn, MA Hughes, DMA Wallace</div><div class="gs_gray">British journal of urology 74 (6), 730-732<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=555086598638502339" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:7H_MAutzIkAC" class="gsc_a_at">Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma</a><div class="gs_gray">AR Davies, D Myoteri, J Zylstra, CR Baker, W Wulaningsih, ...</div><div class="gs_gray">Journal of British Surgery 105 (12), 1639-1649<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17617740029866535044" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:XiVPGOgt02cC" class="gsc_a_at">A review of the issues and challenges involved in using participant‐produced photographs in nursing research</a><div class="gs_gray">C Balmer, F Griffiths, J Dunn</div><div class="gs_gray">Journal of Advanced Nursing 71 (7), 1726-1737<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15258115065501272287" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Genome-wide association study of germline variants and breast cancer-specific mortality</a><div class="gs_gray">M Escala-Garcia, Q Guo, T Dörk, S Canisius, R Keeman, J Dennis, ...</div><div class="gs_gray">British journal of cancer 120 (6), 647-657<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18297224324567978943" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:8xutWZnSdmoC" class="gsc_a_at">Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial</a><div class="gs_gray">PS Hall, A Smith, C Hulme, A Vargas-Palacios, A Makris, ...</div><div class="gs_gray">Value in Health 20 (10), 1311-1318<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16332066918699218545" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:GFxP56DSvIMC" class="gsc_a_at">A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines</a><div class="gs_gray">P Mistry, JA Dunn, A Marshall</div><div class="gs_gray">BMC medical research methodology 17 (1), 1-9<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5278545930323110777" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial</a><div class="gs_gray">HR Ali, A Dariush, J Thomas, E Provenzano, J Dunn, L Hiller, AL Vallier, ...</div><div class="gs_gray">Annals of Oncology 28 (8), 1832-1835<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15198142808944064665" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Effect of using the same vs different order for second readings of screening mammograms on rates of breast cancer detection: a randomized clinical trial</a><div class="gs_gray">S Taylor-Phillips, MG Wallis, D Jenkinson, V Adekanmbi, H Parsons, ...</div><div class="gs_gray">Jama 315 (18), 1956-1965<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=773865863975695238" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:f2IySw72cVMC" class="gsc_a_at">A qualitative systematic review exploring lay understanding of cancer by adults without a cancer diagnosis</a><div class="gs_gray">C Balmer, F Griffiths, J Dunn</div><div class="gs_gray">Journal of Advanced Nursing 70 (8), 1688-1701<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6349739369532669738" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population</a><div class="gs_gray">S Wilson, MJO Wakelam, RFD Hobbs, AV Ryan, JA Dunn, VD Redman, ...</div><div class="gs_gray">BMC cancer 6 (1), 1-7<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12997883802567895418" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:blknAaTinKkC" class="gsc_a_at">Screening for gastric cancer by <i>Helicobacter pylori</i> serology: a retrospective study</a><div class="gs_gray">JL Whiting, MT Hallissey, JWL Fielding, J Dunn</div><div class="gs_gray">Journal of British Surgery 85 (3), 408-411<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15041094690870023264" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:k_IJM867U9cC" class="gsc_a_at">Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial</a><div class="gs_gray">RD Brown, DE Joshua, M Nelson, J Gibson, J Dunn, ICM MacLennan</div><div class="gs_gray">British journal of haematology 84 (2), 238-241<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12193034294139287907" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:UxriW0iASnsC" class="gsc_a_at">A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related&nbsp;…</a><div class="gs_gray">JE Abraham, L Hiller, L Dorling, AL Vallier, J Dunn, S Bowden, S Ingle, ...</div><div class="gs_gray">BMC medicine 13 (1), 1-9<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=92124995699930693" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)</a><div class="gs_gray">A Marshall, M Levine, C Hill, D Hale, J Thirlwall, V Wilkie, K French, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 18 (4), 905-915<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17874827598504006882" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Tackling early morbidity and mortality in myeloma (TEAMM): assessing the benefit of antibiotic prophylaxis and its effect on healthcare associated infections in 977 patients</a><div class="gs_gray">MT Drayson, S Bowcock, T Planche, G Iqbal, J Wood, K Raynes, G Pratt, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 903-903<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7082686907757943162" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">UK ethnicity data collection for healthcare statistics: the South Asian perspective</a><div class="gs_gray">G Iqbal, MRD Johnson, A Szczepura, S Wilson, A Gumber, JA Dunn</div><div class="gs_gray">BMC Public Health 12 (1), 1-9<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5230314062935238998" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK <i>NEAT</i> adjuvant breast cancer trial.</a><div class="gs_gray">J Bartlett, A Munro, J Dunn, L Hiller, S Jordan, C Twelves, D Cameron, ...</div><div class="gs_gray">Cancer Research 69 (2 Supplement), 45<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4089819621385797020" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:48xauSegjOkC" class="gsc_a_at">Double reading in breast cancer screening: cohort evaluation in the CO-OPS trial</a><div class="gs_gray">S Taylor-Phillips, D Jenkinson, C Stinton, MG Wallis, J Dunn, A Clarke</div><div class="gs_gray">Radiology 287 (3), 749-757<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17767116307490675535" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">Reflecting psychoanalysis: Narrative and resolve in the psychoanalytic experience</a><div class="gs_gray">J Reeder</div><div class="gs_gray">Routledge<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14044861082885974721" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:RGFaLdJalmkC" class="gsc_a_at">16. The role of radiotherapy in early breast cancer (stage I). A West Midlands Breast Group prospective randomized collaborative study (BR 3002).</a><div class="gs_gray">D Spooner, JM Morrison, GD Oates, DJ Ellis, MJR Lee, A Aukland, ...</div><div class="gs_gray">The Breast 3 (4), 231-232<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5663810636760998738" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Follow up after transurethral resection of prostate: who needs it?</a><div class="gs_gray">TH Lynch, B Waymont, CJ Beacock, JA Dunn, MA Hughes, DM Wallace</div><div class="gs_gray">BMJ: British Medical Journal 302 (6767), 27<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12150175074180950457" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:M05iB0D1s5AC" class="gsc_a_at"><i>tAnGo</i>: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a&nbsp;…</a><div class="gs_gray">AM Wardley, L Hiller, HC Howard, JA Dunn, A Bowman, RE Coleman, ...</div><div class="gs_gray">British journal of cancer 99 (4), 597-603<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14632686526537283711" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Improving ethnicity data collection for health statistics in the UK</a><div class="gs_gray">G Iqbal, A Gumber, MRD Johnson, A Szczepura, S Wilson, JA Dunn</div><div class="gs_gray">Diversity and Equality in Health and Care 6 (4), 267-285<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10192633701879760645" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer</a><div class="gs_gray">AF Smith, PS Hall, CT Hulme, JA Dunn, CC McConkey, JK Rahman, ...</div><div class="gs_gray">European Journal of Cancer 85, 6-14<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=92105344770603268" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Society and education: An outline of comparison</a><div class="gs_gray">S Moutsios</div><div class="gs_gray">Routledge<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13371942991739306419" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_xSYboBqXhAC" class="gsc_a_at">LIHNCS-Lugol’s iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol’s iodine to assist excision of moderate&nbsp;…</a><div class="gs_gray">JA McCaul, JA Cymerman, S Hislop, C McConkey, J McMahon, ...</div><div class="gs_gray">Trials 14 (1), 1-6<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14698054425851226464" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Socio‐economic deprivation and survival in bladder cancer</a><div class="gs_gray">G Begum, JA Dunn, RT Bryan, S Bathers, DMA Wallace, ...</div><div class="gs_gray">BJU international 94 (4), 539-543<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17574122736940603168" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Cougar-02: A randomized phase III study of docetaxel versus active symptom control in patients with relapsed esophago-gastric adenocarcinoma.</a><div class="gs_gray">N Cook, A Marshall, JM Blazeby, JA Bridgewater, J Wadsley, FY Coxon, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (15_suppl), 4023-4023<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14178344047012472486" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">A randomised controlled trial to evaluate both the role and the optimal fractionation of radiotherapy in the conservative management of early breast cancer</a><div class="gs_gray">D Spooner, DD Stocken, S Jordan, S Bathers, JA Dunn, C Jevons, ...</div><div class="gs_gray">Clinical Oncology 24 (10), 697-706<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16223891384935070300" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment</a><div class="gs_gray">M Jepson, D Elliott, C Conefrey, J Wade, L Rooshenas, C Wilson, ...</div><div class="gs_gray">Journal of clinical epidemiology 99, 75-83<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12648330757378728183" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Adaptive designs for clinical trials assessing biomarker-guided treatment strategies</a><div class="gs_gray">J Wason, A Marshall, J Dunn, RC Stein, N Stallard</div><div class="gs_gray">British journal of cancer 110 (8), 1950-1957<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7577059716588911385" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub‐types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial</a><div class="gs_gray">AM Ali, E Provenzano, JMS Bartlett, J Abraham, K Driver, AF Munro, ...</div><div class="gs_gray">International journal of cancer 133 (6), 1470-1478<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4218035553785534347" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">A network analysis to identify mediators of germline-driven differences in breast cancer prognosis</a><div class="gs_gray">M Escala-Garcia, J Abraham, IL Andrulis, H Anton-Culver, V Arndt, ...</div><div class="gs_gray">Nature communications 11 (1), 1-14<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15732742238527002505" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:w0F2JDEymm0C" class="gsc_a_at">Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part III: outcomes</a><div class="gs_gray">JW Middleton, L Piccenna, RL Gruen, S Williams, G Creasey, S Dunlop, ...</div><div class="gs_gray">Spinal cord 53 (10), 729-737<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14266890128498208637" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:dshw04ExmUIC" class="gsc_a_at">Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497)</a><div class="gs_gray">E Molyneux, B Merrick, FL Khanim, K Banda, JA Dunn, G Iqbal, CM Bunce, ...</div><div class="gs_gray">British journal of haematology 164 (6), 888-90<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17424105200790298058" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) <i>vs</i> CMF in early breast cancer: results with over 7 years median follow-up&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, JA Dunn, AL Vallier, SJ Bowden, SD Jordan, F Blows, ...</div><div class="gs_gray">British journal of cancer 107 (8), 1257-1267<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14543811902233452779" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Treatment preferences of urologists in Great Britain and Ireland in the management of prostate cancer</a><div class="gs_gray">B Waymont, TH Lynch, J Dunn, S Bathers, DMA Wallace</div><div class="gs_gray">British journal of urology 71 (5), 577-582<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12118846948353185932" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_B80troHkn4C" class="gsc_a_at">Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, HC Howard, JA Dunn, J Young, SJ Bowden, ...</div><div class="gs_gray">The Lancet Oncology 18 (6), 755-769<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5040583598707150195" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Assessing violations of the proportional hazards assumption in Cox regression: does the chosen method matter?</a><div class="gs_gray">L Hiller, A Marshall, J Dunn</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10754752108351812357" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3&nbsp;…</a><div class="gs_gray">HM Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 6009-6009<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11739947553901497255" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Urologists' attitudes to the management of bladder cancer</a><div class="gs_gray">TH Lynch, B Waymont, JA DUNN, DMA Wallace</div><div class="gs_gray">British journal of urology 70 (5), 522-525<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6068318880690910304" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:AYInfyleIOsC" class="gsc_a_at">Absence for tumor transmission from a cadaveric renal donor with malignant astrocytoam and a ventriculoperitoneal shunt-two-year recipient follow-up and review of the literature</a><div class="gs_gray">K Delhey, R Lewis, J Dunn, J Berry, R Gray</div><div class="gs_gray">Transplantation 52 (4), 737-738<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2033678784586966049" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy</a><div class="gs_gray">H Mehanna, A Kong, A Hartley, P Mistry, M Dalby, T Fulton-Lieuw, ...</div><div class="gs_gray">Annals of Oncology 29, viii729-viii730<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11714912070376014805" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the long-term outcomes of bladder cancer</a><div class="gs_gray">RT Bryan, T Evans, JA Dunn, G Iqbal, S Bathers, SI Collins, ND James, ...</div><div class="gs_gray">European urology focus 1 (1), 82-89<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11508784902042667538" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma</a><div class="gs_gray">KJ Ishak, JJ Caro, MT Drayson, M Dimopoulos, D Weber, B Augustson, ...</div><div class="gs_gray">Value in Health 14 (5), 672-678<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6185878747282733413" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:rO6llkc54NcC" class="gsc_a_at">Characterization of high‐and low‐grade cervical intraepithelial neoplasia</a><div class="gs_gray">MI Shafi, JA Dunn, CB Finn, S Kehoe, EJ Buxton, JA Jordan, DM Luesley</div><div class="gs_gray">International Journal of Gynecological Cancer 3 (4), 203-207<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16916678941295746097" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Power of oesophageal peristalsis can be controlled voluntarily.</a><div class="gs_gray">RM Valori, MT Hallisey, J Dunn</div><div class="gs_gray">Gut 32 (3), 236-239<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6838311437519634110" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jSAVyFp_754C" class="gsc_a_at">Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial</a><div class="gs_gray">DA Jones, P Mistry, M Dalby, T Fulton-Lieuw, AH Kong, J Dunn, ...</div><div class="gs_gray">European Journal of Cancer 124, 178-185<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1051295606490961598" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WC23djZS0W4C" class="gsc_a_at">Impact of incremental circumferential resection margin distance on overall survival and recurrence in oesophageal adenocarcinoma</a><div class="gs_gray">WRC Knight, J Zylstra, W Wulaningsih, M Van Hemelrijck, D Landau, ...</div><div class="gs_gray">BJS open 2 (4), 229-237<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7554490667047634017" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Considerations for a head and neck smoking cessation support programme; A qualitative study of the challenges in quitting smoking after treatment for head and neck cancer</a><div class="gs_gray">A Abdelrahim, C Balmer, J Jones, H Mehanna, J Dunn</div><div class="gs_gray">European Journal of Oncology Nursing 35, 54-61<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17964292215134283899" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">FKBPL: a marker of good prognosis in breast cancer</a><div class="gs_gray">L Nelson, HD McKeen, A Marshall, L Mulrane, J Starczynski, SJ Storr, ...</div><div class="gs_gray">Oncotarget 6 (14), 12209<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7243134580794264440" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Prednisolone added to the ABCM as treatment for multiple myeloma increases serological responses but not overall survival or the number of stable clinical responses</a><div class="gs_gray">AB Olujohungbe, JA Dunn, MT Drayson, ICM MacLennan</div><div class="gs_gray">British Journal of Haematology 93, 296-296<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5046156158256601824" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">775 Effect of clodronate on progression of skeletal disease in multiple myelomatosis</a><div class="gs_gray">EV McCloskey, ICM MacLennan, M Drayson, C Chapman, J Dunn, ...</div><div class="gs_gray">European Journal of Cancer 31, S162<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5342457927909792374" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Influence of timing of surgery during menstrual cycle on survival of premenopausal women with operable breast cancer</a><div class="gs_gray">PS Stonelake, J Powell, JA Dunn, J Warwickt, SR Bramhall, ...</div><div class="gs_gray">The Breast 4 (1), 19-24<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5084888354449529580" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:a0OBvERweLwC" class="gsc_a_at">Koro presenting after prostatectomy in an elderly man</a><div class="gs_gray">A Puranik, J Dunn</div><div class="gs_gray">British journal of urology (Print) 75 (1), 108-109<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17774208631635051628" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Can we predict a high risk group in stage I epithelial ovarian cancer?</a><div class="gs_gray">CB Finn, J Dunn, EJ Buxton, DM Luesley, M Shafi</div><div class="gs_gray">International Journal of Gynecologic Cancer 3 (4)<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2688833569020763040" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Management of hot flushes in UK breast cancer patients: clinician and patient perspectives</a><div class="gs_gray">D Fenlon, A Morgan, P Khambaita, P Mistry, J Dunn, ML Ah-See, ...</div><div class="gs_gray">Journal of Psychosomatic Obstetrics &amp; Gynecology 38 (4), 276-283<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12436162859075204329" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis trial</a><div class="gs_gray">JSJ Thomas, E Provenzano, L Hiller, J Dunn, C Blenkinsop, L Grybowicz, ...</div><div class="gs_gray">Modern Pathology 30 (8), 1069-1077<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15978447391225106398" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Final results for the AVAST-M trial.</a><div class="gs_gray">P Corrie, A Marshall, P Lorigan, ME Gore, S Tahir, G Faust, CG Kelly, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (15_suppl), 9501-9501<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4127566440368868254" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Abstract P4-11-07: Comparison of multiparameter tests in the UK OPTIMA-Prelim trial</a><div class="gs_gray">JMS Bartlett, RC Stein, J Bayani, A Marshall, JA Dunn, AF Campbell, ...</div><div class="gs_gray">Cancer Research 75 (9 Supplement), P4-11-07-P4-11-07<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5824043201509131010" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">SELECT-D: Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.</a><div class="gs_gray">A Young, J Dunn, O Chapman, J Grumett, A Marshall, J Phillips, A Lokare, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), TPS9661-TPS9661<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5270212580989699144" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Adjuvant and additive therapy for cancer of the pancreas</a><div class="gs_gray">JP Neoptolemos, MG Raraty, P Ghaneh, H Hickey, DD Stocken, JA Dunn, ...</div><div class="gs_gray">Der Chirurg; Zeitschrift fur Alle Gebiete der Operativen Medizen 74 (3), 191-201<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6719637134690011074" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Adjuvant trastuzumab duration trials in HER2 positive breast cancer–what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint results</a><div class="gs_gray">L Hiller, JA Dunn, S Loi, AL Vallier, DL Howe, DA Cameron, D Miles, ...</div><div class="gs_gray">BMC cancer 18 (1), 1-7<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10949931684271857789" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jFemdcug13IC" class="gsc_a_at">Management of advanced head and neck cancer</a><div class="gs_gray">RJD Prestwich, M Sen, AF Scarsbrook</div><div class="gs_gray">New England Journal of Medicine 375 (5), 491-493<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11785272967809465063" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">PERSEPHONE: Duration of trastuzumab with chemotherapy in patients with HER2-positive early breast cancer—Six versus twelve months.</a><div class="gs_gray">HM Earl, DA Cameron, D Miles, AM Wardley, E Ogburn, AL Vallier, S Loi, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), TPS656-TPS656<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10618627480466573708" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:D_sINldO8mEC" class="gsc_a_at">A randomised controlled trial to evaluate both the role and optimal fractionation of radiotherapy in the conservative management of early breast cancer.</a><div class="gs_gray">D Spooner, DD Stocken, S Jordan, S Bathers, JA Dunn, C Jevons, ...</div><div class="gs_gray">Cancer Research 69 (2 Supplement), 5125<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15444514453943396127" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer</a><div class="gs_gray">AV Ryan, S Wilson, MJO Wakelam, SA Warmington, JA Dunn, ...</div><div class="gs_gray">BMC cancer 6 (1), 1-5<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18093675433587285584" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Molecular epidemiology and genetic predisposition for head and neck cancer</a><div class="gs_gray">MR Spitz, Z Trizna</div><div class="gs_gray">Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia, Lippincott&nbsp;…<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15059544516039115357" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non&nbsp;…</a><div class="gs_gray">NP Bailey, NSA Stuart, EM Bessell, JA Child, D Norfolk, J Fletcher, ...</div><div class="gs_gray">Annals of oncology 9 (6), 633-638<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18268266405513293463" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the ‘select-d’Pilot Trial</a><div class="gs_gray">A Young, A Marshall, J Thirlwall, O Chapman, A Lokare, C Hill, D Hale, ...</div><div class="gs_gray">Thrombosis Research 164, S194<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4519048867387126084" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:KxtntwgDAa4C" class="gsc_a_at">ARTemis: A randomised trial of bevacizumab with neoadjuvant chemotherapy (NACT) for patients with HER2-negative early breast cancer—Primary endpoint, pathological complete&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, C Blenkinsop, L Grybowicz, AL Vallier, J Abraham, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), 1014-1014<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6966923988036653243" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Feasibility of recruitment to an oral dysplasia trial in the United Kingdom</a><div class="gs_gray">P Nankivell, J Dunn, M Langman, H Mehanna</div><div class="gs_gray">Head &amp; neck oncology 4 (1), 1-5<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14877272828245688841" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:5ugPr518TE4C" class="gsc_a_at">Ethnicity data collection in the UK: the healthcare professional's perspective</a><div class="gs_gray">G Iqbal, MRD Johnson, A Szczepura, A Gumber, S Wilson, JA Dunn</div><div class="gs_gray">Diversity and Equality in Health and Care 9 (4), 281-290<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15019134721954569057" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:u9iWguZQMMsC" class="gsc_a_at">A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update</a><div class="gs_gray">S Biswas, J Wrigley, C East, A Hern, A Marshall, J Dunn, P Lorigan, ...</div><div class="gs_gray">ecancermedicalscience 2<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6434201904673107933" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Improving ethnic data collection for statistics of cancer incidence, management, mortality and survival in the UK</a><div class="gs_gray">G Iqbal, A Gumber, A Szczepura, M Johnson, S Wilson, J Dunn</div><div class="gs_gray">University of Warwick for Cancer Research UK<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7926612933804973457" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Influence of the type of surgery and surgical complications in the ESPAC-1 adjuvant trial</a><div class="gs_gray">JP Neoptolemos, DD Stocken, JA Dunn, J Buckels, M Deakin, R Sutton, ...</div><div class="gs_gray">British Journal of Surgery-Supplement 89<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3538362361343352387" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:UuEBAcK4md4C" class="gsc_a_at">Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial</a><div class="gs_gray">IN Fernando, SJ Bowden, K Herring, CL Brookes, I Ahmed, A Marshall, ...</div><div class="gs_gray">Radiotherapy and Oncology 142, 52-61<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11072529818498557542" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism</a><div class="gs_gray">JA Dunn, K Jefferson, D MacDonald, G Iqbal, R Bland</div><div class="gs_gray">The Journal of steroid biochemistry and molecular biology 188, 134-140<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8514837094511669091" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:L1USKYWJimsC" class="gsc_a_at">PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Cost effectiveness analysis results</a><div class="gs_gray">C Hulme, P Hall, B Shinkins, F Chehadah, C McCabe, L Hiller, J Dunn, ...</div><div class="gs_gray">Annals of Oncology 29, viii703<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13825904414003025436" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial</a><div class="gs_gray">SE Pinder, AF Campbell, JMS Bartlett, A Marshall, D Allen, M Falzon, ...</div><div class="gs_gray">British journal of cancer 116 (7), 859-863<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13596981690836356655" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WqliGbK-hY8C" class="gsc_a_at">The cost effectiveness of docetaxel and active symptom control versus active symptom control alone for refractory oesophagogastric adenocarcinoma: Economic analysis of the&nbsp;…</a><div class="gs_gray">DM Meads, A Marshall, CT Hulme, JA Dunn, HER Ford</div><div class="gs_gray">PharmacoEconomics 34 (1), 33-42<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7959649951484612003" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Preplanned interim results for the AVAST-M trial.</a><div class="gs_gray">P Corrie, A Marshall, M Goonewardena, JA Dunn, MR Middleton, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (18_suppl), LBA9000-LBA9000<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2313574182889638389,15822161023581097098" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:5icHVeHT4IsC" class="gsc_a_at">for the British Stomach Cancer Group. The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients</a><div class="gs_gray">LC Ward, JWL Fielding, JA Dunn, KA Kelly</div><div class="gs_gray">Br J Cancer 66, 943-50<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12534806303901905003" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial</a><div class="gs_gray">M Vreugdenhil, C Fong, P Sanghera, A Hartley, J Dunn, H Mehanna</div><div class="gs_gray">Oral Oncology 113, 105112<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13458056535565791002" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:zwpXiJ37cpgC" class="gsc_a_at">A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients</a><div class="gs_gray">A Goyal, S Puri, A Marshall, K Valassiadou, MM Hoosein, AR Carmichael, ...</div><div class="gs_gray">Breast Cancer Research and Treatment 185 (2), 433-440<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2285765023338884107" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis</a><div class="gs_gray">R Geach, LI Jones, SA Harding, A Marshall, S Taylor-Phillips, ...</div><div class="gs_gray">Clinical Radiology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17407667566562560952" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:7wO8s98CvbsC" class="gsc_a_at">25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial</a><div class="gs_gray">A Lipplaa, R Fernandes, A Marshall, P Lorigan, J Dunn, KA Myers, ...</div><div class="gs_gray">British journal of cancer 119 (7), 793-800<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7951954584771762176" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:vRqMK49ujn8C" class="gsc_a_at">UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer</a><div class="gs_gray">P Hall, AFC Smith, A Vargas-Palacios, RC Stein, J Bartlett, J Bayani, ...</div><div class="gs_gray">Cancer Research 75 (9)<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7563564887395005874" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Changing case Order to Optimise patterns of Performance in mammography Screening (CO-OPS): study protocol for a randomized controlled trial</a><div class="gs_gray">S Taylor-Phillips, MG Wallis, H Parsons, J Dunn, N Stallard, H Campbell, ...</div><div class="gs_gray">Trials 15 (1), 1-7<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10400061661454737518" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Abstract OT1-1-03: PERSEPHONE: Duration of Trastuzumab with Chemotherapy in women with HER2 positive early breast cancer.</a><div class="gs_gray">HM Earl, DA Cameron, D Miles, AM Wardley, ERM Ogburn, AL Vallier, ...</div><div class="gs_gray">Cancer Research 72 (24 Supplement), OT1-1-03-OT1-1-03<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15006648999120036130" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection</a><div class="gs_gray">DJ Kerr, JA Dunn, MJ Langman, JL Smith, RS Midgley, CL Iveson, ...</div><div class="gs_gray">Journal of Clinical Oncology 26 (15_suppl), 4038-4038<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9895104760689402447" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Survival from relapse and the influence of therapy</a><div class="gs_gray">MT Drayson, BM Augustson, G Begum, JA Dunn, NJ Barth, F Davies, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92 (6), 173-173<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2941974809453035090" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:738O_yMBCRsC" class="gsc_a_at">A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer</a><div class="gs_gray">OP Clinton, TJ Priestman, TN Latief, H Earl, A Murphy, GRP Blackledge, ...</div><div class="gs_gray">Clinical Oncology 7 (4), 251-256<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13433275660754275267" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Qualitative and quantitative analysis of peritoneal fluids from women with gynecologic diseases. Comparison of cytology and flow cytometry for the detection of malignancy in&nbsp;…</a><div class="gs_gray">CB Finn, K Ward, DM Luesley, JA Dunn, CW Redman</div><div class="gs_gray">Analytical and quantitative cytology and histology 13 (3), 182-186<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8232541546317142603" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Hypertension in African populations</a><div class="gs_gray">ARP Walker, KL Mortimer, JW Downing, JA Dunn</div><div class="gs_gray">British Medical Journal 2 (5201), 805<span class="gs_oph">, 1960</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12521032037090638895" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1960</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">Comparison of whole-body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone</a><div class="gs_gray">M Kosmin, AR Padhani, A Gogbashian, D Woolf, ML Ah-See, P Ostler, ...</div><div class="gs_gray">Radiology 297 (3), 622-629<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14126220849285947542" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:2l5NCbZemmgC" class="gsc_a_at">Can mammogram readers swiftly and effectively learn to interpret first post-contrast acquisition subtracted (FAST) MRI, a type of abbreviated breast MRI?: a single centre data&nbsp;…</a><div class="gs_gray">LI Jones, R Geach, SA Harding, C Foy, V Taylor, A Marshall, ...</div><div class="gs_gray">The British journal of radiology 92 (1104), 20190663<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1237823300807624096" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:rmuvC79q63oC" class="gsc_a_at">LIHNCS: Lugol’s Iodine in Head and Neck Cancer Surgery—A multi-centre, randomised, controlled trial assessing the effectiveness of Lugol’s Iodine to assist excision of&nbsp;…</a><div class="gs_gray">JA McCaul, JMM McMahon, J Quantrill, K Gilbert, HM Mehanna, R Shaw, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (15_suppl), 6065-6065<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11215011764668070082" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Cirurgia da Pele</a><div class="gs_gray">JK Robinson, CW Hanke, DM Siegel, A Fratila, AC Bhatia, TE Rohrer</div><div class="gs_gray">Elsevier Brasil<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1292711635139291232" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity: a case-control study</a><div class="gs_gray">L Dorling, S Kar, K Michailidou, L Hiller, AL Vallier, S Ingle, R Hardy, ...</div><div class="gs_gray">PloS one 11 (7), e0158984<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=852940327205132409" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Disease-free (DFS) and overall survival (OS) at 3.4 years (yrs) for neoadjuvant bevacizumab (Bev) added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, J Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), 1014-1014<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15176260013404900214" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Management of advanced nodal disease in patients treated with primary chemoradiotherapy</a><div class="gs_gray">H Mehanna, WL Wong, J Dunn</div><div class="gs_gray">Current opinion in oncology 28 (3), 201-204<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11499992499146068830" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">1809 Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study</a><div class="gs_gray">RC Stein, A Makris, L Hughes-Davies, JMS Bartlett, A Marshall, PS Hall, ...</div><div class="gs_gray">European Journal of Cancer 3 (51), S268<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8524058881899029704" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Follow-up in early breast cancer—a surgical and radiological perceptive</a><div class="gs_gray">JA Dunn, PK Donnelly, A Marshall, M Wilcox, E Watson, A Young, ...</div><div class="gs_gray">Clinical Oncology 26 (10), 625-629<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11692377977026984791" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:t6usbXjVLHcC" class="gsc_a_at">PERSEPHONE is a randomised phase III controlled trial comparing six months of trastuzumab to the standard 12 months in patients with HER2 positive early breast cancer</a><div class="gs_gray">H Earl, D Cameron, D Miles, A Wardley, E Ogburn, AL Vallier, S Loi, ...</div><div class="gs_gray">European Journal of Surgical Oncology 40 (5), 619<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16528274001129315553" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Duplication of Chromosome 17 CEP Predicts for Anthracycline Benefit: A Meta-Analysis of 4 Trials.</a><div class="gs_gray">J Bartlett, A Munro, C Desmedt, J Dunn, D Larsimont, F O'Malley, ...</div><div class="gs_gray">Cancer Research 69 (24 Supplement), 4030-4030<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13169007948843152705" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:sSrBHYA8nusC" class="gsc_a_at">National randomised controlled trial is needed</a><div class="gs_gray">PK Donnelly, L Hiller, JA Dunn</div><div class="gs_gray">Bmj 336 (7642), 461-462<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=230810893899360776" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LPZeul_q3PIC" class="gsc_a_at">aTTom-Adjuvant tamoxifen treatment, offer more?</a><div class="gs_gray">DJ Kerr, HM Earl, PG Baker, CM Jevons, MJ Lee, M Baum, RE Mansel, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 74, SP03-SP03<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7206896869349272985" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:YTuZlYwrTOUC" class="gsc_a_at">Assessing prognosis after neoadjuvant therapy: A comparison between anatomic ypAJCC staging, Residual Cancer Burden Class and Neo-Bioscore</a><div class="gs_gray">MEM van der Noordaa, C Yau, S Shad, M Osdoit, TG Steenbruggen, ...</div><div class="gs_gray">CANCER RESEARCH 81 (4)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15019562790991831644" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:__bU50VfleQC" class="gsc_a_at">Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.</a><div class="gs_gray">H Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, D Rea, ...</div><div class="gs_gray">Health Technology Assessment (Winchester, England) 24 (40), 1<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16498815880301600936" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus</a><div class="gs_gray">WRC Knight, C Yip, W Wulaningsih, A Jacques, N Griffin, J Zylstra, ...</div><div class="gs_gray">BJS open 3 (6), 767-776<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1809971605784882001" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.</a><div class="gs_gray">MT Drayson, S Bowcock, T Planche, G Iqbal, G Pratt, K Yong, J Wood, ...</div><div class="gs_gray">Health technology assessment (Winchester, England) 23 (62), 1-94<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7757523156074724018" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:g3aElNc5_aQC" class="gsc_a_at">OPTIMA: a prospective randomised trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions</a><div class="gs_gray">R Stein, A Makris, L Hughes-Davies, I Macpherson, A Marshall, ...</div><div class="gs_gray">European Journal of Surgical Oncology 42 (11), S229<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5585474246685261833" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry</a><div class="gs_gray">SA Huish, S Fletcher, JA Dunn, M Hewison, R Bland</div><div class="gs_gray">The Journal of steroid biochemistry and molecular biology 164, 214-217<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5260455867655357423" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">OPTIMA: a prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive&nbsp;…</a><div class="gs_gray">SA Dotchin, V Harmer15, A Morgan16, B Shinkins17, N Stallard, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11263730517163223463" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">PERSEPHONE: Duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer—Six versus twelve months.</a><div class="gs_gray">HM Earl, DA Cameron, D Miles, AM Wardley, E Ogburn, AL Vallier, S Loi, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (15_suppl), TPS667-TPS667<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15045021586720584054" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:JQOojiI6XY0C" class="gsc_a_at">The PERSEPHONE trial: Duration of Trastuzumab with Chemotherapy in women with HER-2 positive early breast cancer</a><div class="gs_gray">HM Earl, DA Cameron, D Miles, AM Wardley, E Ogburn, AM Vallier, S Loi, ...</div><div class="gs_gray">J Clin Oncol 30 (suppl), abstrTPS660<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12432981990774105628" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer.</a><div class="gs_gray">HM Earl, C Blenkinsop, L Grybowicz, AL Vallier, DA Cameron, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (15_suppl), TPS1144-TPS1144<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12176734632113250607" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:8AbLer7MMksC" class="gsc_a_at">Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse</a><div class="gs_gray">PG de Takats, JA Dunn, DJ Kerr, JM Morrison</div><div class="gs_gray">Cancer treatment reviews 19, 11-19<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2636479018890989024" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Combination chemotherapy for myelomatosis</a><div class="gs_gray">M Clarke, R Gray, J Dunn, I Maclennan</div><div class="gs_gray">Lancet (British edition) 340 (8816)<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8191243686767327199" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training</a><div class="gs_gray">JMS Bartlett, J Bayani, EN Kornaga, P Danaher, C Crozier, T Piper, ...</div><div class="gs_gray">PloS one 15 (9), e0238593<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14213694152879584619" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">Estimating Contralateral Breast Cancer Risk from Photons versus Protons in Patients Undergoing Internal Mammary Nodal Breast Cancer Radiotherapy</a><div class="gs_gray">S Settatree, D Brand, A Ranger, A Dunlop, E Harris, S Gulliford, A Kirby</div><div class="gs_gray">Clinical Oncology 32 (5), 342<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2082635683761515896,6749043087378556336" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Cisplatin reduces costs and provides more quality adjusted life years (QALYs) than cetuximab in chemoradiotherapy for patients with HPV-positive oropharyngeal cancer (HPV+ OPC)</a><div class="gs_gray">DA Jones, H Mehanna, P Mistry, M Dalby, T Fulton-Lieuw, AH Kong, ...</div><div class="gs_gray">Annals of Oncology 30, v450-v451<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12909890738494254733" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Self reflections of undergraduate students on using web-supported counterintuitive science demonstrations</a><div class="gs_gray">DD Kumar, J Dunn</div><div class="gs_gray">Journal of Science Education and Technology 27 (4), 362-368<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17460745389570423941" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Levofloxacin prophylaxis in newly diagnosed myeloma reduces febrile episodes and death without increasing healthcare associated infections: Results from the TEAMM trial&nbsp;…</a><div class="gs_gray">S Bowcock, T Planche, G Iqbal, G Pratt, K Yong, J Wood, K Raynes, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 16-17<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11481319835071701730" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:1taIhTC69MYC" class="gsc_a_at">Use of circulating tumor DNA to predict survival in patients with resected high-risk stage II/III melanoma.</a><div class="gs_gray">R Lee, G Gremel, A Marshall, KA Myers, N Fisher, P Corrie, J Dunn, ...</div><div class="gs_gray">Journal of Clinical Oncology 35 (15_suppl), 9583-9583<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8720639368363950264" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Bladder cancer risk is associated with low serum 25-hydroxyvitamin D levels; a systematic review</a><div class="gs_gray">C Chivu, J Dunn, B Rosemary, K Jefferson, D MacDonald, G Iqbal</div><div class="gs_gray">European Journal of Surgical Oncology 42 (11), S239<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10930892193452582716" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Radiation therapy variation in the randomized phase 3 positron emission tomography neck study</a><div class="gs_gray">A Hartley, C Fong, P Sanghera, WL Wong, C McConkey, J Rahman, ...</div><div class="gs_gray">International Journal of Radiation Oncology, Biology, Physics 96 (2), S117<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17675525770054867556" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:JWITY9-sCbMC" class="gsc_a_at">head and neck cancer</a><div class="gs_gray">AF Smith, PS Hall, C Hulme, C McConkey, JA Dunn, J Rahman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10969571830722216206" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Is PET-CT guided management for patients with locally advanced head and neck squamous cell cancer (HNSCC) cost-effective? Results from a UK non-inferiority phase III randomized&nbsp;…</a><div class="gs_gray">AF Smith, P Hall, C Hulme, J Dunn, JK Rahman, CC McConkey, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 6010-6010<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3445210720630096040" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Management of hot flushes in UK breast cancer patients: comparing the clinician and patient perspective</a><div class="gs_gray">D Fenlon, J Armes, J Dunn, J Filshie, M Hunter, ML Ah-See, A Morgan, ...</div><div class="gs_gray">Maturitas 81 (1), 138<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1420747168131082631" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Abstract PD2-3: ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer</a><div class="gs_gray">HM Earl, L Hiller, JA Dunn, C Blenkinsop, L Grybowicz, AL Vallier, ...</div><div class="gs_gray">Cancer Research 75 (9 Supplement), PD2-3-PD2-3<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2614467254190209927" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Systematic review of interventions to increase recruitment and retention of black, minority and ethnic patients into randomised controlled trials</a><div class="gs_gray">G Iqbal, J Dunn, M Thorogood</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11893796089304199553" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:olpn-zPbct0C" class="gsc_a_at">Neo-tAnGo science: A translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.</a><div class="gs_gray">HM Earl, SF Chin, M Dunning, M Iddawela, O Rueda, R Russell, L Jones, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (15_suppl), 1015-1015<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16472361665656157281" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:W5xh706n7nkC" class="gsc_a_at">OP025: Epidemiology of human papilloma virus associated oropharyngeal cancer in England and Wales: Recent UK estimates in the last decade from the (PET-NECK) randomised&nbsp;…</a><div class="gs_gray">K Louie, O Olaleye, J Dunn, P Sasieni, H Mehanna</div><div class="gs_gray">Oral Oncology 49, S13-S14<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14565853857786872722" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Ehil0879vHcC" class="gsc_a_at">LIHNCS; randomised control trial in oral and maxillofacial surgery interim data and recruitment report</a><div class="gs_gray">JA McCaul, R Kulkarni, D Gouldesbrough, T Boye, D Sutton, K Abdel-Galil, ...</div><div class="gs_gray">British Journal of Oral and Maxillofacial Surgery 50, S22<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18152661734775859784" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NJ774b8OgUMC" class="gsc_a_at">195 Patient's experiences of a pre and post surgery rehabilitation programme for lung cancer (Rehabilitation Of lung Cancer (ROC) programme): a qualitative interview study</a><div class="gs_gray">A Parsons, A Bradley, L Reaper, C Jordan, A Paul, G Dowswell, J Dunn, ...</div><div class="gs_gray">Lung Cancer, S64<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15178298066136949128" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HE397vMXCloC" class="gsc_a_at">VICTOR: a phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection</a><div class="gs_gray">RSJ Midgley, CC McConkey, MJ Langman, JL Smith, P Julier, C Iveson, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17749926864977852076" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: A non-randomised&nbsp;…</a><div class="gs_gray">DW Rea, L Hiller, HM Earl, JA Dunn, S Bathers, D Spooner, RJ Grieve, ...</div><div class="gs_gray">Journal of Clinical Oncology 22 (14_suppl), 595-595<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5781633757373356599" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Adjuvante und additive Therapie beim Pankreaskarzinom</a><div class="gs_gray">JP Neoptolemos, MGT Raraty, P Ghaneh, H Hickey, DD Stocken, ...</div><div class="gs_gray">Der Chirurg 74 (3), 191-201<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4034952140896723259" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Survival, quality of life and quality-adjusted survival of patients in the ESPAC-1 trial: a European randomized trial to assess the rules of adjuvant chemotherapy and&nbsp;…</a><div class="gs_gray">JP Neoptolemos, DD Moffitt, JA Dunn, J Almond, HG Beger, KH Link, ...</div><div class="gs_gray">BRITISH JOURNAL OF SURGERY 88, 31-31<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15820167430351213177,8622220358942507699" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer</a><div class="gs_gray">JP Neoptolemos, DD Moffitt, JA Dunn, J Almond, HG Beger, KH Link, ...</div><div class="gs_gray">European Journal of Cancer 37, S253-S253<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1099130378040113375" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Long term follow-up after radiotherapy for muscle-invasive bladder cancer</a><div class="gs_gray">PW Cooke, DMA Wallace, J Dunn, S Bathers, T Latief, ND James</div><div class="gs_gray">British Journal of Cancer 78, 10-10<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5806883766304059377" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:eflP2zaiRacC" class="gsc_a_at">Effect of clodronate on the natural history of myelomatosis</a><div class="gs_gray">JA Kanis, EV McCloskey, I MacLennan, M Drayson, C Chapman, J Dunn</div><div class="gs_gray">British Journal of Haematology 93, 1136-1136<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17676874358473388056" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">The prognostic significance of intraperitoneal growth characteristics in epithelial ovarian carcinoma</a><div class="gs_gray">P Van Geene, R Varma, J Dunn, KK Chan, DM Luesle</div><div class="gs_gray">International Journal of Gynecological Cancer 6 (3), 219-224<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3255551076218465140" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">alpha 2b-interferon treatment used in plateau phase of multiple myeloma increases relapse free interval but not overall survival.</a><div class="gs_gray">MT Drayson, JA Dunn, AB Olujohungbe, ICM MacLennan</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 208-208<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9932358239261083384" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:c59VksA5Vz4C" class="gsc_a_at">Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score</a><div class="gs_gray">COVIDSurg Collaborative</div><div class="gs_gray">The British journal of surgery<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5904089703545548982,6169738675612266137" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Abstract GS4-07: Assessing prognosis after neoadjuvant therapy: A comparison between anatomic ypAJCC staging, residual cancer burden class and neo-bioscore</a><div class="gs_gray">MEM van der Noordaa, C Yau, S Shad, M Osdoit, TG Steenbruggen, ...</div><div class="gs_gray">Cancer Research 81 (4 Supplement), GS4-07-GS4-07<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6730622542323983021" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management</a><div class="gs_gray">IJ Chicca, JLJ Heaney, G Iqbal, JA Dunn, S Bowcock, G Pratt, KL Yong, ...</div><div class="gs_gray">Blood cancer journal 10 (11), 1-12<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7714049828306689387" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:YlPif8NxrbYC" class="gsc_a_at">Strategies to improve recruitment to a de-escalation trial: a mixed-methods study of the OPTIMA prelim trial in early breast cancer</a><div class="gs_gray">C Conefrey, JL Donovan, RC Stein, S Paramasivan, A Marshall, J Bartlett, ...</div><div class="gs_gray">Clinical Oncology 32 (6), 382-389<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17191174618608899203" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">MAMMO-50: mammographic surveillance in breast cancer patients over 50 years of age</a><div class="gs_gray">R Audisio, P Donnelly, A Evans, A Marshall, M Ramirez, H Higgins, ...</div><div class="gs_gray">European Journal of Surgical Oncology 46 (2), e18-e19<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13982884948366945176" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:qwy9JoKyICEC" class="gsc_a_at">Levofloxacin prophylaxis in patients with myeloma–Authors' reply</a><div class="gs_gray">MT Drayson, S Bowcock, T Planche, G Iqbal, G Pratt, K Yong, JA Dunn</div><div class="gs_gray">The Lancet Oncology 21 (2), e69<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10406733807735743660" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:s85pQhAUCrAC" class="gsc_a_at">Corrigendum: Adjuvant bevacizumab for melanoma patients at high risk of recurrence: Survival analysis of the AVAST-M trial (Annals of Oncology (2018) 29: 8 (1843-1852</a><div class="gs_gray">PG Corrie, A Marshall, PD Nathan, P Lorigan, M Gore, S Tahir, G Faust, ...</div><div class="gs_gray">Annals of Oncology 30 (12), 2013-2014<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18442034332940809809" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:wKETBy42zhYC" class="gsc_a_at">The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial&nbsp;…</a><div class="gs_gray">DJ Lin, CC McConkey, P Nankivell, J Dunn, H Mehanna</div><div class="gs_gray">Oral oncology 85, 40-43<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7875605611014797111" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in&nbsp;…</a><div class="gs_gray">S Bowcock, C Atkin, G Iqbal, T Planche, G Pratt, K Yong, J Wood, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2132&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8139924838439494281" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">From plateau to MRD-Negative CR: outcomes in the MRC/NCRI series of randomised trials in newly diagnosed patients with multiple myeloma from 1980 to 2016</a><div class="gs_gray">D Cairns, W Gregory, J Dunn, G Iqbal, I MacLennan, A Rawstron, R Owen, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 17 (1), e60<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1950843417871027952" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:L_l9e5I586QC" class="gsc_a_at">Phase 2 of CATALISE: a multinational and multidisciplinary Delphi consensus study...</a><div class="gs_gray">CA Greenhalgh, L Archibald, G Baird, A Bauer, J Bellair, C Boyle, ...</div><div class="gs_gray">Journal of Child Psychology and Psychiatry 58 (10), 1068-1080<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2290196334381412831" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Low vitamin D is associated with increased bladder cancer risk; a systematic review and evidence of a potential mechanism</a><div class="gs_gray">R Bland, C Chivu, K Jefferson, D MacDonald, G Iqbal, J Dunn</div><div class="gs_gray">Society for Endocrinology BES 2016 44<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8133110734828241614" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">The role of PET CT in the management of advanced nodal head neck cancer post chemoradiotherapy</a><div class="gs_gray">WL Wong, J Dunn, H Mehanna</div><div class="gs_gray">Translational Cancer Research 5, S932-S932<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11089510516519213465" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:N5tVd3kTz84C" class="gsc_a_at">PET-CT surveillance for advanced head and neck cancer: a cost-effective alternative to planned neck dissection?</a><div class="gs_gray">AF Smith, PS Hall, C Hulme, C McConkey, JA Dunn, J Rahman, ...</div><div class="gs_gray">Annals of Oncology 27, vi329<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8999095354926368871,8133922482394727975" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">De-ESCALaTE: Comparison of early and late toxic events in low-risk HPV positive oropharyngeal carcinoma patients treated with chemoradiotherapy, cetuximab versus cisplatin.</a><div class="gs_gray">HM Mehanna, CC McConkey, AGJ Hartley, MT Fulton-Lieuw, J Grumett, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), TPS6103-TPS6103<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11012835358986280724" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:umqufdRvDiIC" class="gsc_a_at">Abstract PD2-02: NEO-EXCEL phase III neoadjuvant trial of pre-operative exemestane or letrozole+/-celecoxib in the treatment of ER positive postmenopausal early breast cancer</a><div class="gs_gray">D Rea, A Francis, C Poole, C Brookes, R Stein, J Bartlett, J Dunn, ...</div><div class="gs_gray">Cancer Research 76 (4 Supplement), PD2-02-PD2-02<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12769742889738878127" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Use of patient diaries in conjunction with standard reporting methods: duplication of data or a valuable resource?</a><div class="gs_gray">J Dunn, B Harris, G Iqbal, J Wood, P Mistry, J O'Beirne-Elliman, ...</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14018357993141260316" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">LIHNCS (Lugol's Iodine in Head and Neck Cancer Surgery) a UK multicentre prospective randomised controlled trial. Report of primary and secondary outcome measures</a><div class="gs_gray">J McCaul, D Sutton, R Shaw, H Mehanna, S Hislop, J McMahon, J Dunn</div><div class="gs_gray">International Journal of Oral and Maxillofacial Surgery 44, e111<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4897613201223486946" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SdhP9T11ey4C" class="gsc_a_at">11LBA Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV-patients receiving primary chemoradiotherapy in PET&nbsp;…</a><div class="gs_gray">H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...</div><div class="gs_gray">European Journal of Cancer 3 (51), S715<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7060342437823135043" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:35r97b3x0nAC" class="gsc_a_at">Predicting anthracycline benefit: TOP2A and CEP17-not only but also</a><div class="gs_gray">JMS Bartlett, CC McConkey, AF Munro, C Desmedt, JA Dunn, ...</div><div class="gs_gray">European Journal Of Cancer 50, S164-S164<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=262644808612517211" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions</a><div class="gs_gray">P Hall, C McCabe, C Hulme, R Edlin, J Dunn, D Cameron, R Stein</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12514299738228699346" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">OPTIMA prelim: Optimal personalized treatment of early breast cancer using multiparameter analysis: Preliminary study.</a><div class="gs_gray">R Stein, A Makris, L Hughes-Davies, JA Dunn, JMS Bartlett, J Donovan, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (15_suppl), TPS665-TPS665<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12477790618765610297" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Neo-escape: Neoadjuvant extended sequential chemotherapy with adjuvant postoperative treatment for epithelial nonmucinous advanced inoperable peritoneal malignancy.</a><div class="gs_gray">CJ Poole, A Marshall, HB Higgins, J Fletcher, SJ Williams, N Lo, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (15_suppl), 5046-5046<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12834944122366469885" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Optimising patient recall of adverse events over prolonged time periods</a><div class="gs_gray">L Hiller, JA Dunn, HB Higgins, E Ogburn-Storey, S Loi, AL Vallier, HM Earl</div><div class="gs_gray">Trials 12 (1), 1-1<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8090619790465569070" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Modelling the cost-effectiveness of first, second and third generation polychemotherapy regimens in women with early breast cancer who have differing prognoses.</a><div class="gs_gray">H Campbell, D Epstein, S Griffin, M Sculpher, A Manca, D Bloomfield, ...</div><div class="gs_gray">Cancer Research 69 (2 Supplement), 6106<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17025899667661051916" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Clinical trials in oncology</a><div class="gs_gray">T Friede, J Dunn, N Stallard</div><div class="gs_gray">Anticancer Therapeutics, 365<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=867263090676275968" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hkOj_22Ku90C" class="gsc_a_at">The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: The updated&nbsp;…</a><div class="gs_gray">H Earl, L Hiller, JA Dunn, S Bathers, RJ Grieve, D Spooner, RK Agrawal, ...</div><div class="gs_gray">Journal of Clinical Oncology 25 (18_suppl), 534-534<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11864407632945998431" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:zUl2_INMlC4C" class="gsc_a_at">The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials; the updated&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, JA Dunn, S Bathers, RJ Grieve, D Spooner, RK Agrawal, ...</div><div class="gs_gray">Journal of Clinical Oncology 2007 25 (185), 11S<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12787856893971912708" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk&nbsp;…</a><div class="gs_gray">C Poole, L Hiller, H Howard, S Loi, J Dunn, P Canney, A Wardley, ...</div><div class="gs_gray">Breast Cancer Research and Treatment 100<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11983784205202288178" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Early Mortality Following Diagnosis of Multiple Myeloma; Analysis of Patients Entered into the UK Medical Research Council Trials 1980–2002.</a><div class="gs_gray">BM Augustson, G Begum, NJ Barth, JA Dunn, GJ Morgan, JA Child, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 3465-3465<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7452300637177571162" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">A prospective evaluation of pulmonary, cardiac, and hepatic function (fn) in ‘<i>tAnGo’:</i> A randomized phase III trial of gemcitabine (G) in paclitaxel (T)-containing&nbsp;…</a><div class="gs_gray">CJ Poole, HC Howard, L Hiller, JA Dunn, AM Wardley, A Bowman, ...</div><div class="gs_gray">Journal of Clinical Oncology 22 (14_suppl), 821-821<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2008748635287240383" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Progress by collaboration: ESPAC studies</a><div class="gs_gray">R Sutton, DD Stocken, JA Dunn, H Hickey, MGT Raraty, P Ghaneh, ...</div><div class="gs_gray">Pancreatic Disease, 57-69<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14563028978468981472" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Tolerability (toxicity, dose intensity and quality adjusted survival (QAS)) of ECMF versus CMF in the national epirubicin adjuvant trial (NEAT) of moderate risk early breast&nbsp;…</a><div class="gs_gray">H Earl, C Poole, J Dunn, L Hiller, S Bathers, D Spooner, R Grieve, ...</div><div class="gs_gray">Breast Cancer Research and Treatment 76<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8073502782526530794" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Influence of resection margins on survival for patients with resectable pancreatic cancer treated with chemoradiation or chemotherapy within the European Study Group for&nbsp;…</a><div class="gs_gray">JP Neoptolemos, DD Stocken, JA Dunn, J Almond, HG Beger, C Bassi, ...</div><div class="gs_gray">BRITISH JOURNAL OF SURGERY 89 (3), 377-377<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17110120468970126414" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Survival and quality of life (QoL) of patients in ESPAC-1: A european, randomised study of assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic&nbsp;…</a><div class="gs_gray">JP Neoptolemos, DD Moffitt, JA Dunn, J Almond, HG Beger, C Bassi, ...</div><div class="gs_gray">Gastroenterology 5 (120), A24-A25<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5705230623785229303" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Systematic review of factors influencing clinicians and patients participation in clinical trials</a><div class="gs_gray">LC Ward, JA Dunn, G Slegg, P Harvey, MT Hallissey, C Hyde, G Begum, ...</div><div class="gs_gray">Sydney<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2266500479022007627" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Cytological prediction of cervical intraepithelial neoplasia grade 3: does size of the lesion matter?</a><div class="gs_gray">IJ Etherington, DM Luesley, MI Shafi, J Dunn, JA Jordan</div><div class="gs_gray">Journal of lower genital tract disease 2 (1), 17-18<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13118573293124801925" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:F9fV5C73w3QC" class="gsc_a_at">0-63. Pathological and immunohistochemical prognostic factors in clinical stage I breast cancer patients</a><div class="gs_gray">RA Walker, PS Stonelake, JA Dunn, PR Baker, CM Jevons, L Dodson, ...</div><div class="gs_gray">The Breast 4 (6), 242<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17839053594538047330" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:geHnlv5EZngC" class="gsc_a_at">8 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 4. Assessing the effect of chemotherapy across prognostic strata in over 800 randomised&nbsp;…</a><div class="gs_gray">MH Cullen, LJ Billingham, J Dunn</div><div class="gs_gray">Lung Cancer, 4-5<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=190218967523011629" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">34. Pathological and immunohistochemical prognostic factors in clinically node-negative breast cancer patients receiving adjuvant tamoxifen (BR3002 trial)</a><div class="gs_gray">PR Baker, RA Walker, JA Dunn, SM Parnell, PS Stonelake, CM Jevons, ...</div><div class="gs_gray">The Breast 3 (4), 237<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18280871437968704301" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">CHEMOTHERAPY TYPE AND GOOD PERFORMANCE STATUS IMPROVE RESPONSE IN PATIENTS WITH RECURRENT CERVICAL-CANCER</a><div class="gs_gray">J Buxton, R Coleman, K Towlson, P Harper, E Wiltshaw, J Dunn, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 60 (3), 453-453<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5556476301309101167" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Xl6nMSl579sC" class="gsc_a_at">PHOTOGRAPHIC EXPOSURE TIMERS PROVIDING COMPENSATION FOR SUPPLY VOLTAGE VARIATIONS-BEFORE THE MEASUREMENTS SECTION, 17TH FEBRUARY, 1953-DISCUSSION</a><div class="gs_gray">RSJ SPILSBURY, JF DUNN, RJ HERCOCK, DM NEALE, LC WALSHE</div><div class="gs_gray">PROCEEDINGS OF THE INSTITUTION OF ELECTRICAL ENGINEERS-LONDON 100 (76), 386-388<span class="gs_oph">, 1953</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6756283257512182196" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1953</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation</a><div class="gs_gray">S LJ, B JM, R CA, T KM, S RC, C AJ, B DJ, D JL, CA Rogers, R Andrews, ...</div><div class="gs_gray">Journal of Clinical Epidemiology 106<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9270139388630768867" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BOlwja0KXvYC" class="gsc_a_at">Development and validation of an improved classification and risk stratification system for carotid body tumors: A multinational collaborative cohort study</a><div class="gs_gray">H Mehanna, P Mistry, P Golusinski, PD Maio, P Nankivell, F Snider, ...</div><div class="gs_gray">Head &amp; Neck<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study</a><div class="gs_gray">M Vreugdenhil, C Fong, G Iqbal, T Roques, M Evans, N Palaniappan, ...</div><div class="gs_gray">Clinical Oncology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jmjb1lOE9QIC" class="gsc_a_at">Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study</a><div class="gs_gray">JMS Bartlett, J Bayani, E Kornaga, K Xu, GR Pond, T Piper, E Mallon, ...</div><div class="gs_gray">NPJ Breast Cancer 7 (1), 1-13<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:wLxue7F8ec0C" class="gsc_a_at">Abbreviated breast MRI (FAST MRI): A multi-centre reader-training study for NHS Breast Screening Programme (NHSBSP) multi-professional mammogram readers (funded by the National&nbsp;…</a><div class="gs_gray">L Jones, R Geach, S Harding, A Marshall, S McKeown-Keegan, ...</div><div class="gs_gray">BREAST CANCER RESEARCH 23<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BmWJbWwHJAwC" class="gsc_a_at">Commentary on: Introduction of an abbreviated breast MRI service in the UK as part of the BRAID trial: practicalities, challenges, and future directions</a><div class="gs_gray">LI Jones, JA Dunn</div><div class="gs_gray">Clinical Radiology 76 (6), 434-435<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed&nbsp;…</a><div class="gs_gray">RC Stein, A Makris, IR MacPherson, L Hughes-Davies, A Marshall, ...</div><div class="gs_gray">Journal of Clinical Oncology 39 (15_suppl), TPS599-TPS599<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Identification of good and poor prognosis HPV associated oropharyngeal cancer based on CD103 immune cell expression in patients treated with cetuximab and radiotherapy on TROG&nbsp;…</a><div class="gs_gray">D Rischin, HM Mehanna, RJ Young, M Bressel, J Dunn, J Corry, ...</div><div class="gs_gray">Journal of Clinical Oncology 39 (15_suppl), 109-109<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:t-hv7AR41mYC" class="gsc_a_at">Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy (ATNEC).</a><div class="gs_gray">A Goyal, S Cramp, D Wheatley, A Marshall, S Puri, N Hammonds, ...</div><div class="gs_gray">Journal of Clinical Oncology 39 (15_suppl), TPS600-TPS600<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:nqdriD65xNoC" class="gsc_a_at">Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial</a><div class="gs_gray">A Marshall, AM Young, M Levine, C Hill, D Hale, J Thirlwall, V Wilkie, ...</div><div class="gs_gray">THROMBOSIS RESEARCH 200, S36-S36<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LGlY6t8CeOMC" class="gsc_a_at">PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial</a><div class="gs_gray">A Marshall, AM Young, M Levine, C Hill, D Hale, J Thirlwall, V Wilkie, ...</div><div class="gs_gray">Thrombosis Research 200, S36<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial</a><div class="gs_gray">C Atkin, G Iqbal, T Planche, G Pratt, K Yong, J Wood, K Raynes, E Low, ...</div><div class="gs_gray">British journal of haematology 192 (6), 997-1005<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SxCCDk4iOpsC" class="gsc_a_at">Abstract PD13-02: Site of recurrence after neoadjuvant therapy: A multi-center pooled analysis</a><div class="gs_gray">S Shad, M van der Noordaa, M Osdoit, D de Croze, AS Hamy, M Lae, ...</div><div class="gs_gray">Cancer Research 81 (4 Supplement), PD13-02-PD13-02<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:YB4bud6kWLwC" class="gsc_a_at">Abstract OT-04-01: Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy-ATNEC&nbsp;…</a><div class="gs_gray">A Goyal, S Cramp, D Wheatley, A Marshall, S Puri, T Homer, L Vale, R Mir, ...</div><div class="gs_gray">Cancer Research 81 (4 Supplement), OT-04-01-OT-04-01<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:RtRctb2lSbAC" class="gsc_a_at">Abstract PS3-31: Training multi-professional mammogram readers to interpret abbreviated breast MRI (FAST MRI): A UK multi-centre study</a><div class="gs_gray">LIL Jones, R Geach, SA Harding, A Marshall, S McKeown-Keegan, ...</div><div class="gs_gray">Cancer Research 81 (4 Supplement), PS3-31-PS3-31<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:mel-f30kHHgC" class="gsc_a_at">Abstract PS1-32: A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients</a><div class="gs_gray">A Goyal, S Puri, A Marshall, K Valassiadou, M Hoosein, AR Carmichael, ...</div><div class="gs_gray">Cancer Research 81 (4 Supplement), PS1-32-PS1-32<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hGdtkIFZdKAC" class="gsc_a_at">Quality of Life Data from a Prospective Randomised Trial of Newly Diagnosed Myeloma Patients with Renal Failure: Optimal Trial</a><div class="gs_gray">K Ramasamy, G Iqbal, MT Drayson, R Brouwer, S Varghese, S Schey, ...</div><div class="gs_gray">Blood 136, 5-6<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">OC-0573: Improvement in late dysphagia following clinical target volume reduction in the De-ESCALaTE study</a><div class="gs_gray">CTK Fong, P Mistry, T Roques, M Evans, HQ Yang, L O'Toole, ...</div><div class="gs_gray">Radiotherapy and Oncology 152, S320-S321<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:-yGd096yOn8C" class="gsc_a_at">Cardiac toxicity</a><div class="gs_gray">H Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, D Rea, ...</div><div class="gs_gray">Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">Methods: recruitment and study conduct</a><div class="gs_gray">H Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, D Rea, ...</div><div class="gs_gray">Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:unp9ATQDT5gC" class="gsc_a_at">Health economic analysis and cost-effectiveness analysis</a><div class="gs_gray">H Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, D Rea, ...</div><div class="gs_gray">Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">Quality of life, patient-reported experiences and reporting of results to patients</a><div class="gs_gray">H Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, D Rea, ...</div><div class="gs_gray">Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:eGYfIraVYiQC" class="gsc_a_at">ATNEC: axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy ClinicalTrials. gov&nbsp;…</a><div class="gs_gray">A Goyal, A Marshall, D Wheatley, S Ahmed, B Elsberger, A Shaaban, ...</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 545-545<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">OPTIMA: a prospective randomised trial to validate tumour gene expression test-directed chemotherapy decisions in high-risk hormone-sensitive early breast cancer</a><div class="gs_gray">RC Stein, A Marshall, A Makris, L Hughes-Davies, IR MacPherson, ...</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 542-543<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">SENTINUS: phase II trial of intradermal microbubbles and contrast-enhanced ultrasound for identifying sentinel lymph node metastases in breast cancer patients</a><div class="gs_gray">K Cox, A Marshall, N Sharma, D Dodwell, C Kirwan, R Millican-Slater, ...</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 586-586<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Feasibility of training NHS breast screening programme (NHSBSP) mammogram readers to interpret abbreviated breast MRI (FAST MRI)</a><div class="gs_gray">LI Jones, R Geach, S Harding, J Wookey, A Marshall, S Vinnicombe, ...</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 585-585<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Patient reported experiences collected in the PERSEPHONE Herceptin duration trial</a><div class="gs_gray">J Dunn, M Wilcox, S Gasson, L Hiller, A Wardley, D Cameron, D Miles, ...</div><div class="gs_gray">BREAST CANCER RESEARCH AND TREATMENT 180 (2), 535-536<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:27LrP4qxOz0C" class="gsc_a_at">Protective strategies to prevent trastuzumab-induced cardiotoxicity–Authors' reply</a><div class="gs_gray">HM Earl, L Hiller, C Plummer, D Miles, AM Wardley, DA Cameron, ...</div><div class="gs_gray">The Lancet 395 (10223), 492-493<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in&nbsp;…</a><div class="gs_gray">RC Stein, A Marshall, A Makris, L Hughes-Davies, IR MacPherson, ...</div><div class="gs_gray">Cancer Res 80 (4 Supplement), OT3-17-01<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:naSTrk-c4S8C" class="gsc_a_at">surveyed breast oncologists in the UK, for their views on the recommendations from the Working Group for 6 months adjuvant trastuzumab. The following three questions were&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, J Dunn, I Macpherson, D Rea, L Hughes-Davies, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NMlhSUseqAsC" class="gsc_a_at">Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study</a><div class="gs_gray">IJ Chicca, JLJ Heaney, G Iqbal, JA Dunn, S Bowcock, T Planche, G Pratt, ...</div><div class="gs_gray">Efficacy and Mechanism Evaluation 7 (10)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training</a><div class="gs_gray">J Bayani, EN Kornaga, P Danaher, C Crozier, T Piper, CQ Yao, JA Dunn</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">Improving outcomes for women diagnosed with early breast cancer through Adherence to adjuvant endocrine therapy (SWEET)</a><div class="gs_gray">L Sharp, E Watson, M Wells, R Horne, L Hiller, A Todd, J Wolstenholme, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Let's talk about Sex: Comparing clinician and patient perspectives in the management of sexual difficulties in UK women after breast cancer treatment</a><div class="gs_gray">A Morgan, L Turner, AC Armstrong, E Pennery, S Stanway, J Noble, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kJDgFkosVoMC" class="gsc_a_at">Abbreviated Breast MRI-a systematic review</a><div class="gs_gray">R Geach, S Harding, A Marshall, J Dunn, L Jones</div><div class="gs_gray">BREAST CANCER RESEARCH 21<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Optimal-a Study of Bortezomib, Bendamustine and Dexamethasone (BBD) Vs Thalidomide, Bendamustine and Dexamethasone (BTD) in Patients with Renal Failure Defined As an Egfr below&nbsp;…</a><div class="gs_gray">K Ramasamy, MT Drayson, G Iqbal, V Stalker, S Akhtar, J Dunn, S Schey</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Health economic analysis</a><div class="gs_gray">MT Drayson, S Bowcock, T Planche, G Iqbal, G Pratt, K Yong, J Wood, ...</div><div class="gs_gray">Prophylactic levofloxacin to prevent infections in newly diagnosed&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">The importance of continued follow-up in cancer trials: results from the TEAMM myeloma trial assessing the benefit of 12 weeks levofloxacin prophylaxis on febrile episodes or&nbsp;…</a><div class="gs_gray">G Iqbal, M Drayson, S Bowcock, T Planche, J Dunn</div><div class="gs_gray">Trials 20, 76<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:TlpoogIpr_IC" class="gsc_a_at">MAMMO-50-Working with the patients to enable multiple types of data collection within a clinical trial</a><div class="gs_gray">M Ramirez, A Marshall, J Lindley, A Bhandari, A Young, M Wilcox, ...</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Strategies to improve recruitment to a trial of less treatment: a mixed methods study of the OPTIMA prelim trial in early breast cancer</a><div class="gs_gray">C Conefrey, J Donovan, S Paramasivan, R Stein, J Bartlett, D Cameron, ...</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Investigating the application of a multi-arm, multi-stage (MAMS) design to compare optimal treatment duration of Herceptin in a non-inferior setting in treating early breast&nbsp;…</a><div class="gs_gray">P Mistry, JA Dunn, L Hiller, A Marshall</div><div class="gs_gray">TRIALS 20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">6 versus 12 months of adjuvant trastuzumab in patients with HER2 positive breast cancer (PERSEPHONE): definitive 4-year disease-free survival results of an open label&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, A Vallier, S Loi, K McAdam, L Hughes-Davis, AN Harnett, ...</div><div class="gs_gray">Elsevier<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Analysis of hydration and antiemetics policies in preventing cisplatin-related gastrointestinal and renal toxicities in low-risk human papillomavirus positive-oropharyngeal&nbsp;…</a><div class="gs_gray">AH Kong, P Mistry, M Evans, AGJ Hartley, T Fulton-Lieuw, D Jones, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (15_suppl), 6076-6076<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">OC-011 New insights from the De-ESCALate HPV trial</a><div class="gs_gray">H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...</div><div class="gs_gray">Radiotherapy and Oncology 132, 10-11<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HGTzPopzzJcC" class="gsc_a_at">Abstract OT1-05-02: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in&nbsp;…</a><div class="gs_gray">RC Stein, L Hughes-Davies, A Makris, IR Macpherson, C Conefrey, ...</div><div class="gs_gray">Cancer Research 79 (4 Supplement), OT1-05-02-OT1-05-02<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:DrR-2ekChdkC" class="gsc_a_at">Statistical considerations in a non-inferiority trial: results from the PERSEPHONE early breast cancer herceptin duration trial</a><div class="gs_gray">JA Dunn, L Hiller, D Howe, AL Vallier, K Raynes, H Higgins, DA Cameron, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Cost effectiveness analyses of 6 versus 12 months of adjuvant trastuzumab in patients with HER2 positive early breast cancer: Results from the PERSEPHONE trial</a><div class="gs_gray">C Hulme, P Hall, B Shinkins, F Chehadah, C McCabe, J Dunn, L Hiller, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 119 (11), 49-49<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:PyEswDtIyv0C" class="gsc_a_at">Comparison of performance of mammogram readers with breast MRI readers at an abbreviated breast MRI interpretation task: Results from a single centre multireader study using an&nbsp;…</a><div class="gs_gray">L Jones, S Harding, R Geach, C Foy, V Taylor, A Marshall, J Dunn</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 119 (11), 28-29<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Tackling early morbidity and mortality in myeloma (TEAMM): assessing the benefit of antibiotic prophylaxis and its effect on healthcare associated infections in 977 patients</a><div class="gs_gray">M Drayson, S Bowcock, T Planche, G Iqbal, K Raynes, G Pratt, K Yong, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 119 (11), 44-44<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Response evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging</a><div class="gs_gray">M Kosmin, AR Padhani, A Gogbashian, D Woolf, ML Ah-See, P Ostler, ...</div><div class="gs_gray">Annals of Oncology 29, viii102-viii103<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Radical treatment of muscle-invasive bladder cancer—are options equal?</a><div class="gs_gray">D Fackrell, A Marshall, P Mistry, J Dunn, M De Santis, D Ford, A Zarkar</div><div class="gs_gray">Journal of Radiation Oncology 7 (2), 181-186<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Patient’s perspective of living with and beyond the treatment of trastuzumab: Results from the PERSEPHONE early breast cancer trial.</a><div class="gs_gray">J Dunn, L Hiller, C Balmer, M Wilcox, AL Vallier, S Gasson, C Hulme, ...</div><div class="gs_gray">Journal of Clinical Oncology 36 (15_suppl), e22101-e22101<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Major changes in levels of regulatory cytokines and functional antibodies contribute to severe immunodeficiency of myeloma patients and persist at one year post diagnosis</a><div class="gs_gray">IJ Chicca, JLJ Heaney, G Iqbal, S Bowcock, T Planche, J Wood, K Raynes, ...</div><div class="gs_gray">HAEMATOLOGICA 103, 15-15<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Presenting symptoms of patients with multiple myeloma: Data from the TEAMM (Tackling EArly Morbidity and Mortality in Myeloma) trial</a><div class="gs_gray">C Atkin, M Drayson, G Iqbal, K Yong, G Pratt, T Planche, J Wood, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 96-96<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Does a long diagnostic pathway in myeloma lead to more advanced disease at presentation? An analysis from the TEAMM trial (Tackling EArly Morbidity and Mortality in Myeloma)</a><div class="gs_gray">S Bowcock, C Atkin, G Iqbal, K Yong, G Pratt, T Planche, J Wood, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 99-100<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Abstract OT1-06-01: OPTIMA: A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in&nbsp;…</a><div class="gs_gray">RC Stein, A Makris, L Hughes-Davies, IR Macpherson, PS Hall, ...</div><div class="gs_gray">2017 San Antonio Breast Cancer Symposium; December 5-9, 2017;<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:U_HPUtbDl20C" class="gsc_a_at">PERSEPHONE: a randomised phase 3 non-inferiority trial of 6 versus 12 months (m) of adjuvant trastuzumab in patients with HER2 positive (+) early breast cancer (EBC)</a><div class="gs_gray">H Earl, L Hiller, L Vallier, S Loi, D Howe, H Higgins, K McAdam, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:-jrNzM816MMC" class="gsc_a_at">Patient reported experiences (PREs) from the PERSEPHONE early breast cancer (EBC) trial</a><div class="gs_gray">J Dunn, M Wilcox, C Balmer, S Gasson, L Hiller, L Vallier, C Hulme, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management</a><div class="gs_gray">I Chicca, JLJ Heaney, G Iqbal, S Bowcock, T Planche, J Wood, K Raynes, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 3036-3036<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">1, 25-dihydroxyvitamin D deficiency in haemodialysis patients is corrected by vitamin D supplementation</a><div class="gs_gray">S Huish, C Jenkinson, S Fletcher, J Dunn, M Hewison, R Bland</div><div class="gs_gray">Endocrine Abstracts 50<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:uWiczbcajpAC" class="gsc_a_at">Cabazitaxel in patients with locally advanced or metastatic transitional cell carcinoma who developed disease progression within 12 months of platinum based chemotherapy&nbsp;…</a><div class="gs_gray">A Zarkar, A Marshall, J Dunn, A Davies, D Ford, ND James</div><div class="gs_gray">Journal of Clinical Oncology 35 (15_suppl), 4542-4542<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:u-coK7KVo8oC" class="gsc_a_at">A literature review of the use of adaptive design methods in oncology trials</a><div class="gs_gray">P Mistry, J Dunn, A Marshall</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Value of a sister observational cohort alongside a randomised controlled trial with an internal feasibility phase</a><div class="gs_gray">J Dunn, A Marshall, M Ramirez, A Evans, P Donnelly</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Pragmatic integrated randomised controlled trials in screening: experience from a trial in 1.2 million women attending breast screening</a><div class="gs_gray">S Taylor-Phillips, D Jenkinson, M Wallis, J Dunn, A Clarke</div><div class="gs_gray">TRIALS 18<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Economic evaluation</a><div class="gs_gray">H Mehanna, CC McConkey, JK Rahman, WL Wong, AF Smith, C Nutting, ...</div><div class="gs_gray">PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Comparing clinician and patient perspectives in the management of hot flushes in UK breast cancer patients</a><div class="gs_gray">A Morgan, ML Ah-See, M Hunter, J Armes, J Filshie, L Turner, C Morris, ...</div><div class="gs_gray">BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY 124, 101-101<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Central Pathology Review with Two-Stage Quality Assurance for Pathological Response After Neoadjuvant Chemotherapy in the ARTemis Trial</a><div class="gs_gray">E Provenzano, JS Thomas, L Hiller, J Dunn, C Blenkinsop, L Grybowicz, ...</div><div class="gs_gray">JOURNAL OF PATHOLOGY 241, S10-S10<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Gemcitabine added to paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for women with early stage breast cancer (tAnGo): an open-label, randomised&nbsp;…</a><div class="gs_gray">HM Earl, L Hiller, HC Howard, JA Dunn, J Young, SJ Bowden, ...</div><div class="gs_gray">Oncology 18 (6), 755-769<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tYavs44e6CUC" class="gsc_a_at">Smoking after cancer: A qualitative study of the challenges in quitting smoking after a diagnosis of, and treatment for, head and neck cancer</a><div class="gs_gray">A Abdelrahim, C Balmer, H Mehanna, J Jones, J Dunn</div><div class="gs_gray">European Journal of Surgical Oncology 42 (11), S253<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Xz60mAmATU4C" class="gsc_a_at">The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study</a><div class="gs_gray">L Wilson, S Kar, K Michailidou, L Hiller, AL Vallier, S Ingle, R Hardy, ...</div><div class="gs_gray">Public Library of Science<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:fFSKOagxvKUC" class="gsc_a_at">OPTIMA (Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of&nbsp;…</a><div class="gs_gray">A Makris, L Hughes-Davies, IR MacPherson, A Marshall, AF Campbell, ...</div><div class="gs_gray">Journal of Clinical Oncology 34 (15_suppl), TPS623-TPS623<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:3htObqc8RwsC" class="gsc_a_at">OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of&nbsp;…</a><div class="gs_gray">A Francis, RC Stein, A Marshall, DW Rea, DA Cameron, IR Macpherson, ...</div><div class="gs_gray">European Journal of Surgical Oncology 42 (5), S9-S10<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism</a><div class="gs_gray">A Young, J Phillips, H Hancocks, C Hill, N Joshi, A Marshall, J Grumett, ...</div><div class="gs_gray">THROMBOSIS RESEARCH 140, S172-S173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Chemotherapy versus Supportive Care Alone for Relapsed Gastric, Gastroesophageal Junction and Oesophageal Adenocarcinoma: a Meta-analysis of Patient Level Data</a><div class="gs_gray">T Janowitz, P Thuss-Patience, A Marshall, JH Kang, C Connell, N Cook, ...</div><div class="gs_gray">Nature Publishing Group<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">NEO-EXCEL phase III neoadjuvant trial of pre-operative exemestane or letrozole plus/-celecoxib in the treatment of ER positive postmenopausal early breast cancer</a><div class="gs_gray">D Rea, A Francis, C Poole, C Brookes, R Stein, J Bartlett, J Dunn, ...</div><div class="gs_gray">CANCER RESEARCH 76<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">OPTIMA (optimal personalised treatment of early breast cancer using multi-parameter analysis), a prospective trial to validate the predictive utility and cost-effectiveness of&nbsp;…</a><div class="gs_gray">RC Stein, A Marshall, PS Hall, JMS Bartlett, L Rooshenas, A Campbell, ...</div><div class="gs_gray">CANCER RESEARCH 76<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Abstract OT3-02-12: OPTIMA (optimal personalised treatment of early breast cancer usIng multi-parameter analysis), a prospective trial to validate the predictive utility and&nbsp;…</a><div class="gs_gray">RC Stein, A Marshall, PS Hall, JMS Bartlett, L Rooshenas, A Campbell, ...</div><div class="gs_gray">Cancer Research 76 (4 Supplement), OT3-02-12-OT3-02-12<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Health utility literature review</a><div class="gs_gray">RC Stein, JA Dunn, JMS Bartlett, AF Campbell, A Marshall, P Hall, ...</div><div class="gs_gray">OPTIMA prelim: a randomised feasibility study of personalised care in the&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Methods: pathology and health economic study</a><div class="gs_gray">RC Stein, JA Dunn, JMS Bartlett, AF Campbell, A Marshall, P Hall, ...</div><div class="gs_gray">OPTIMA prelim: a randomised feasibility study of personalised care in the&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Results: recruitment and study conduct</a><div class="gs_gray">RC Stein, JA Dunn, JMS Bartlett, AF Campbell, A Marshall, P Hall, ...</div><div class="gs_gray">OPTIMA prelim: a randomised feasibility study of personalised care in the&nbsp;…<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">CATALISE: A multinational and multidisciplinary Delphi consensus study. Identifying language impairments in children</a><div class="gs_gray">MJ Snowling, PA Thompson, T Greenhalgh, C Adams, L Archibald, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:q-HalDI95KYC" class="gsc_a_at">Geographic variation in human papillomavirus–related oropharyngeal cancer</a><div class="gs_gray">H Mehanna, N Franklin, N Compton, M Robinson, N Powell, L Junor, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">The madness of HIV prevention trials</a><div class="gs_gray">S McCormack</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:lvd772isFD0C" class="gsc_a_at">Photochemical internalisation of bleomycin with TPCS2a in patients with solid malignancies: phase I results and de-escalation of dose extension</a><div class="gs_gray">N Berridge, K Tzanidakis, C Hopper, M Forster, AA Sultan, W Jerjes</div><div class="gs_gray">British Journal of Oral and Maxillofacial Surgery 53 (10), e112<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">Under-representation of male patients in breast cancer studies</a><div class="gs_gray">P Mistry, L Hiller, G Iqbal, J Dunn</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:yB1At4FlUx8C" class="gsc_a_at">The use of early decision modelling and value of information analysis in an adaptive trial design: results from the OPTIMA preliminary study</a><div class="gs_gray">P Hall, A Smith, C Hulme, A Vargas-Palacios, J Dunn, A Marshall, ...</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:z_wVstp3MssC" class="gsc_a_at">Practicalities of using an adaptive design for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests</a><div class="gs_gray">J Dunn, A Marshall, A Campbell, D Cameron, H Earl, I Macpherson, ...</div><div class="gs_gray">Trials 16 (2), 1-1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Vitamin D deficiency in haemodialysis patients; treatment with colecalciferol</a><div class="gs_gray">S Huish, S Fletcher, J Dunn, M Hewison, R Bland</div><div class="gs_gray">Endocrine Abstracts 38<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:p__nRnzSRKYC" class="gsc_a_at">P175. MAMMO-50: Mammographic surveillance in breast cancer patients over 50 years of age–The results of the 2 year feasibility study</a><div class="gs_gray">P Donnelly, A Evans, J Dunn</div><div class="gs_gray">European Journal of Surgical Oncology 41 (6), S75<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WZBGuue-350C" class="gsc_a_at">Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer</a><div class="gs_gray">PS Hall, AF Smith, A Vargas-Palacios, RC Stein, J Bartlett, J Bayani, ...</div><div class="gs_gray">Cancer Research 75 (9 Supplement), P6-08-11-P6-08-11<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">EP-1156 Dosimetric impact of anatomic and volumetric methods of target outlining on normal structures in a UK clinical trial</a><div class="gs_gray">W Owadally, H Baines, M Evans, G Jones, J Henderson, E Miles, J Dunn, ...</div><div class="gs_gray">Radiotherapy and Oncology 115, S628-S629<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">3rd International Clinical Trials Methodology Conference</a><div class="gs_gray">S McCormack, P Horby, CT Smith, C Hopkins, M Sydes, K Woolfall, ...</div><div class="gs_gray">Trials 16 (2), I1<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:UmS_249rOGwC" class="gsc_a_at">Cost-Utility of Cancer Therapies–the'Cost'of Different Utility Generation Strategies</a><div class="gs_gray">DM Meads, C McCabe, CT Hulme, R Edlin, SA Kharroubi, C Browne, ...</div><div class="gs_gray">Value in Health 17 (7), A327<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Successful Recruitment to Head &amp; Neck Trials: lessons learned from the LIHNCS Trial</a><div class="gs_gray">J McCaul, J Cymerman, R Kulkarni, K Gilbert, A Pendrill, J Quantrill, ...</div><div class="gs_gray">British Journal of Oral and Maxillofacial Surgery 52 (8), e65<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3&nbsp;…</a><div class="gs_gray">PG Corrie, A Marshall, JA Dunn</div><div class="gs_gray">LANCET ONCOLOGY 15 (9), E365-E365<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:0N-VGjzr574C" class="gsc_a_at">Cardiology monitoring substudy in the PERSEPHONE trial: 6 versus 12 months of trastuzumab.</a><div class="gs_gray">L Hiller, AL Vallier, E Ogburn, AM Wardley, DA Cameron, D Miles, J Dunn, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), 552-552<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">The current management of vasomotor symptoms in breast cancer patients in the UK: Clinician versus patient perspective. NCRI Breast CSG Working Party on Symptom Management&nbsp;…</a><div class="gs_gray">M Ah-See, C Coles, D Fenlon, E Pennery, J Dunn, A Morgan</div><div class="gs_gray">EUROPEAN JOURNAL OF CANCER 50, S88-S89<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Is it me or is it hot in here? Hot flushes (or flashes): An unmet need. UK NCRI breast clinical studies group working party on symptom management (vasomotor)</a><div class="gs_gray">A Morgan, D Fenlon, C Coles, A Armstrong, K Randle, A Thompson, ...</div><div class="gs_gray">CANCER RESEARCH 73<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Abstract OT1-1-08: PERSEPHONE: Duration of trastuzumab with chemotherapy in women with HER-2+ ve early breast cancer</a><div class="gs_gray">HM Earl, AL Vallier, E Ogburn-Storey, DA Cameron, AM Wardley, D Miles, ...</div><div class="gs_gray">Cancer Research 73 (24 Supplement), OT1-1-08-OT1-1-08<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Abstract P3-08-09: Is it me or is it hot in here? Hot flushes (or flashes): An unmet need. UK NCRI breast clinical studies group working party on symptom management (vasomotor)</a><div class="gs_gray">A Morgan, D Fenlon, C Coles, A Armstrong, K Randle, A Thompson, ...</div><div class="gs_gray">Cancer Research 73 (24 Supplement), P3-08-09-P3-08-09<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Using adaptive designs for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests</a><div class="gs_gray">J Dunn, A Marshall, A Campbell, N Stallard, C Hulme, P Hall, H Higgins, ...</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:DUooU5lO8OsC" class="gsc_a_at">The challenges of using radiological ‘tumour response'as an outcome: lessons learned from neo-tango and artemis, two neo-adjuvant chemotherapy breast cancer trials</a><div class="gs_gray">L Hiller, J Dunn, AL Vallier, C Blenkinsop, L Grybowicz, H Higgins, H Earl</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">An adaptive biomarker strategy clinical trial design</a><div class="gs_gray">J Wason, N Stallard, J Dunn, R Stein</div><div class="gs_gray">Trials 14 (1), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Effect of BRAF mutation status on adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence</a><div class="gs_gray">P Corrie, A Marshall, N Davison, S Danson, P Nathan, M Marples, ...</div><div class="gs_gray">Pigment Cell &amp; Melanoma Research 26 (6)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Feasibility and surgeon acceptability of visualisation with Lugol's iodine (VILI) in the LIHNCS trial</a><div class="gs_gray">JA McCaul, J Cymerman, DN Sutton, RJ Shaw, S Hislop, J Adamson, ...</div><div class="gs_gray">British Journal of Oral and Maxillofacial Surgery 51 (6), e91-e92<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">OPTIMA prelim: Optimal personalized treatment of early breast cancer using multiparameter tests.</a><div class="gs_gray">R Stein, A Makris, L Hughes-Davies, AF Campbell, A Marshall, ...</div><div class="gs_gray">Journal of Clinical Oncology 31 (15_suppl), TPS656-TPS656<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">OP080: LIHNCS trial (Lugol’s iodine in head and neck cancer surgery): Interim recruitment and data report</a><div class="gs_gray">JA McCaul, A Pendrill, J Quantrill, H Mehanna, C McKonkey, J Dunn</div><div class="gs_gray">Oral Oncology 49, S37<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Breast cancer surgery for the elderly–are we meeting a growing need?</a><div class="gs_gray">S Olsen, M Davies, J Dunn</div><div class="gs_gray">European Journal of Surgical Oncology 39 (5), 497<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Abstract OT3-3-09: ARTemis trial-randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer</a><div class="gs_gray">HM Earl, C Blenkinsop, L Grybowicz, AL Vallier, DA Cameron, ...</div><div class="gs_gray">Cancer Research 72 (24 Supplement), OT3-3-09-OT3-3-09<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:CYCckWUYoCcC" class="gsc_a_at">Feasibility of recruitment to an oral dysplasia trial in the United Kingdom: W076</a><div class="gs_gray">P Nankivell, M Langman, J Dunn, H Mehanna</div><div class="gs_gray">Clinical Otolaryngology 37<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">LIHNCS trial: Lugol's iodine in head and neck cancer surgery.</a><div class="gs_gray">JA Dunn, R Kulkarni, D Gouldesbrough, H Mehanna, JMM McMahon, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (15_suppl), e16042-e16042<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Using photovoice to study the experience of living with and beyond the diagnosis of a poor prognostic cancer</a><div class="gs_gray">C Balmer</div><div class="gs_gray">BMJ Supportive &amp; Palliative Care 2 (Suppl 1), A28-A28<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:lYAcb2jw7qUC" class="gsc_a_at">Population Health Scientist, Methodology Research Fellowships and Career Development Award in Biostatistics Panel</a><div class="gs_gray">M Campbell, G Hart, V Farewell, D Ashby, J Brazier, J Dunn, V Entwistle, ...</div><div class="gs_gray">University of Manchester<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">192 Can the thoracoscore and revised cardiac risk index predict outcomes?</a><div class="gs_gray">M Abdelaziz, A Marshall, K Hussain, A Bradley, P Agostini, E Bishay, ...</div><div class="gs_gray">Lung Cancer, S63<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:e_rmSamDkqQC" class="gsc_a_at">OT1-02-08: The PERSEPHONE Trial: Duration of Trastuzumab with Chemotherapy in Women with HER2 Positive Early Breast Cancer. Changing the Randomisation Point To Address&nbsp;…</a><div class="gs_gray">HM Earl, S Loi, AL Vallier, L Hiller, E Ogburn-Storey, H Higgins, J Dunn</div><div class="gs_gray">Cancer Research 71 (24 Supplement), OT1-02-08-OT1-02-08<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:0izLItjtcgwC" class="gsc_a_at">The importance of planning for a seamless transition in an adaptive phase II randomised trial</a><div class="gs_gray">A Marshall, JA Dunn, J Fletcher, HB Higgins, CJ Poole</div><div class="gs_gray">Trials 12 (1), 1-1<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:anf4URPfarAC" class="gsc_a_at">Abstract C51: Molecular markers, prognosis, and efficacy of adjuvant anthracyclines in breast cancer.</a><div class="gs_gray">AMG Ali, E Provenzano, J Abraham, K Driver, JMS Bartlett, A Munro, ...</div><div class="gs_gray">Molecular Cancer Therapeutics 10 (11 Supplement), C51-C51<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial.</a><div class="gs_gray">AMG Ali, E Provenzano, J Abraham, JM Bartlett, CJ Poole, L Hiller, ...</div><div class="gs_gray">Journal of Clinical Oncology 29 (27_suppl), 12-12<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Challenges in Setting Up a Multicentre National Trial Assessing Quality of Life and Function</a><div class="gs_gray">H Mehanna, C Balmer, C Nutting, S Fisher, W Wong, J Dunn</div><div class="gs_gray">CLINICAL ONCOLOGY 21 (8), 644-645<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Addressing Biased Survival Due To Crossover in Trials: A315</a><div class="gs_gray">G Morgan, R Knight, K Ishak, M Drayson, M Dimopoulos, D Weber, ...</div><div class="gs_gray">Clinical Lymphoma &amp; Myeloma 9<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">Involving patients in clinical trial design: the experience of the UK Ibreast early breast cancer follow-up trial</a><div class="gs_gray">J Dunn, M Wilcox, F Taggert, C Hulme, J Tritter, J Austoker, J Mossman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:cWzG1nlazyYC" class="gsc_a_at">A315 Addressing Biased Survival Due To Crossover in Trials</a><div class="gs_gray">GJ Morgan, RD Knight, KJ Ishak, MT Drayson, MA Dimopoulos, ...</div><div class="gs_gray">Clinical Lymphoma &amp; Myeloma, S50-S51<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Étude randomisée de phase III comparant gemcitabine à gemcitabine plus capécitabine chez des patients attaints d’un cancer du pancreas de stade avancé</a><div class="gs_gray">D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, ...</div><div class="gs_gray">J Clin Oncol 27, 5513-5518<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography?</a><div class="gs_gray">WL Wong, C Nutting, J Dunn, S Fisher, K MacLennan, C MacCabe, ...</div><div class="gs_gray">Nuclear medicine communications 30 (1), 2-4<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:nZcligLrVowC" class="gsc_a_at">ADJUVANT BEVACIZUMAB IS SAFE TREATMENT FOR MELANOMA PATIENTS AT HIGH RISK OF RECURRENCE</a><div class="gs_gray">S Biswas, C East, A A'Hern, A Marshall, J Dunn, P Lorigan, M Middleton, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 245-245<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">A NOVEL APPROACH TO ADJUST FOR THE IMPACT ON SURVIVAL RESULTING FROM PATIENT CROSS-OVER FROM CONTROL TO EXPERIMENTAL TREATMENT IN CLINICAL TRIALS: PSY 10</a><div class="gs_gray">K Ishak, B Deniz, M Drayson, G Morgan, B Augustson, J Child, G Begum, ...</div><div class="gs_gray">Value in Health 11 (3)<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">PSY10 A NOVEL APPROACHTO ADJUST FOR THE IMPACT ON SURVIVAL RESULTING FROM PATIENT CROSS-OVER FROM CONTROLTO EXPERIMENTAL TREATMENT IN CLINICAL TRIALS</a><div class="gs_gray">KJ Ishak, B Deniz, M Drayson, GJ Morgan, BM Augustson, JA Child, ...</div><div class="gs_gray">Value in Health 11 (3), A155<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:foquWX3nUaYC" class="gsc_a_at">Modeling overall survival in the event of patient cross-over from dexamethasone to lenalidomide in phase III multiple myeloma trials: 327</a><div class="gs_gray">K Ishak, B Deniz, M Drayson, G Morgan, B Augustson, A Child, G Begum, ...</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:hQUaER0FWQ4C" class="gsc_a_at">The CanEth project: improving ethnicity data collection for statistics of cancer incidence, prevalence and survival in the UK</a><div class="gs_gray">G Begum, A Gumber, M Johnson, A Szczepura, S Wilson, J Dunn</div><div class="gs_gray">NCRI Cancer Conference<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Rofecoxib and cardiovascular adverse events in adjuvant</a><div class="gs_gray">JA Dunn, DJ Kerr, MJ Langman, JL Smith, RS Midgley</div><div class="gs_gray">statement: Not available online<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">O-110 The challenges of using radiological ‘tumour response’as an endpoint in Neo-tAnGo: a national neo-adjuvant chemotherapy breast cancer trial</a><div class="gs_gray">L Hiller, N Fenwick, AL Vallier, JA Dunn, S Hilborne, L Jones, J Abraham, ...</div><div class="gs_gray">EJC Supplements 3 (5), 33-34<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LK8CI43ZvvMC" class="gsc_a_at">New referrals to colorectal clinics: symptom profiles anxiety and quality of life</a><div class="gs_gray">S Wilson, C McConkey, A Ryan, T Ismail, J Dunn, F Hobbs</div><div class="gs_gray">NCRI Cancer Conference<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">Changes in the serum proteome associated with docetaxel chemotherapy</a><div class="gs_gray">ND James, D Ward, A Martin, D Barton, J Dunn, E Porfiri</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 20036-20036<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Epirubicin and cyclophosphamide, methotrexate, and</a><div class="gs_gray">CJ Poole, HM Earl, L Hiler, JA Dunn, S Bathers, RJ Grieve</div><div class="gs_gray">statement: Not available online<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:isU91gLudPYC" class="gsc_a_at">Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival</a><div class="gs_gray">K Kikuchi, H Koyama, H Masuda, Y Nomura, D Sakai, K Sugimachi, ...</div><div class="gs_gray">The Lancet 366 (9503), 2087-2106<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ye4kPcJQO24C" class="gsc_a_at">PHASE III RANDOMISED COMPARISON OF GEMCITABINE (GEM) WITH GEMCITABINE PLUS CAPECITABINE (GEM-CAP) IN PATIENTS WITH ADVANCED PANCREATIC CANCER</a><div class="gs_gray">JP Neoptolemos, I Chau, D Stocken, C Davies, J Dunn, J Valle, D Smith, ...</div><div class="gs_gray">Pancreas 31 (4), 459<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Unusual presentation of multiple endocrine neoplasia 2A</a><div class="gs_gray">P Saravanan, L Goss, J Dunn, R Paisey, J Rankin, K MacLeod</div><div class="gs_gray">Endocrine Abstracts 9<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:pQTOvowfQioC" class="gsc_a_at">Early diagnosis of colorectal cancer: establishing the value of MMP9</a><div class="gs_gray">S Wilson, A Ryan, T Ismail, M Wakelam, J Dunn, F Hobbs</div><div class="gs_gray">Family Practice 22<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:nPT8s1NX_-sC" class="gsc_a_at">Early diagnosis of colorectal cancer: establishing the value of MMP9 (oral)</a><div class="gs_gray">S Wilson, T Ismail, A Ryan, M Wakelam, J Dunn, F Hobbs</div><div class="gs_gray">The Scottish School of Primary Care Annual Conference<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:oPLKW5k6eA4C" class="gsc_a_at">Early diagnosis of colorectal cancer</a><div class="gs_gray">S Wilson, A Ryan, T Ismail, M Wakelam, J Dunn, F Hobbs</div><div class="gs_gray">WONCA Europe 2005, 11th conference of the European Society of General Practice<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Cosentini, EP 203 Cuesta, MA 419 Deakin, M. 353 de Boer, MT 265</a><div class="gs_gray">SMM de Castro, CHC Dejong, KP de Jong, CP Delaney, PT den Hoed, ...</div><div class="gs_gray">Dig Surg 22, 484<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Original Reports-HEMATOLOGIC MALIGNANCIES-Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council&nbsp;…</a><div class="gs_gray">BM Augustson, G Begum, JA Dunn, NJ Barth, F Davies, G Morgan, ...</div><div class="gs_gray">Journal of Clinical Oncology 23 (36), 9219-9226<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:YohjEiUPhakC" class="gsc_a_at">Long-term survival in patients receiving conventional therapy for newly diagnosed multiple myeloma; Results from United Kingdom medical research council trials 1980-1997.</a><div class="gs_gray">BM Augustson, G Begum, GJ Morgan, JA Child, NJ Barth, JA Dunn, ...</div><div class="gs_gray">BLOOD 104 (11), 312B-312B<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Long-Term Survival in Patients Receiving Conventional Therapy for Newly Diagnosed Multiple Myeloma; Results from United Kingdom Medical Research Council Trials 1980–1997.</a><div class="gs_gray">BM Augustson, G Begum, GJ Morgan, JA Child, NJ Barth, JA Dunn, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 4921-4921<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:vbGhcppDl1QC" class="gsc_a_at">The establishment of a portfolio of liver cancer trials within a UK clinical trials unit</a><div class="gs_gray">DP Brant, JM Barnwell, JA Dunn, PJ Johnson</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 91, S77-S77<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">ESPAC-1: final results of a European, randomized controlled trial to assess the roles of adjuvant chemotherapy and adjuvant chemoradiation in resectable pancreatic cancer</a><div class="gs_gray">D Stocken, J Neoptolemos, H Friess, C Bassi, J Dunn, H Hickey, C Imrie, ...</div><div class="gs_gray">British Journal of Surgery 91 (4)<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Hasnyálmirigydaganat gyógyszeres kezelése Dr. Bodoky György Szent László Kórház Onkológiai Osztály</a><div class="gs_gray">JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ...</div><div class="gs_gray">N Engl J Med 350 (12), 1200-10<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:z8nqeaKD1nsC" class="gsc_a_at">Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: A non-randomised&nbsp;…</a><div class="gs_gray">DW Hiller, HM Earl, JA Dunn, S Bathers, D Spooner, R Grieve, ...</div><div class="gs_gray">Meetings Proceedings book Abstract no 595 23, 25<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Cost-effectiveness analysis of PET-CT guided management for locally advanced head</a><div class="gs_gray">AF Smith, PS Hall, CT Hulme, JA Dunn, CC McConkey, JK Rahman, ...</div><div class="gs_gray">otolaryngology–head &amp; neck surgery 130 (7), 861-7<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Development of an improved staging system to predict both survival and specific disease outcomes in multiple myeloma</a><div class="gs_gray">JA Dunn</div><div class="gs_gray">University of Birmingham<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">IgD Myeloma; The medical research council (MRC) UK experience.</a><div class="gs_gray">S Makkuni, S Basu, G Begum, JA Dunn, NJ Barth, MT Drayson</div><div class="gs_gray">BLOOD 102 (11), 449A-449A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Does the paraprotein and lightchain subclass affect survival in myeloma? An analysis of 2745 patients from medical research council (MRC) UK myeloma trials.</a><div class="gs_gray">S Basu, G Begum, S Makkuni, JA Dunn, MT Drayson</div><div class="gs_gray">BLOOD 102 (11), 448A-448A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Designing clinical trials to impact on clinical practice</a><div class="gs_gray">J Dunn, C McConkey, D Stocken</div><div class="gs_gray">CONTROLLED CLINICAL TRIALS 24, 124S-124S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Hazard function-A useful tool for exploring survival data</a><div class="gs_gray">G Begum, J Dunn</div><div class="gs_gray">CONTROLLED CLINICAL TRIALS 24, 60S-60S<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Meta-analysis of-adjuvant chemoradiotherapy and chemotherapy for resectable pancreatic cancer including the final results of the ESPAC-1 trial</a><div class="gs_gray">JP Neoptolemos, DD Stocken, JA Dunn, KE Bakkevold, J Jeekel, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 86, S1-S1<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:dBIO0h50nwkC" class="gsc_a_at">The effect of material deprivation on survival in bladder cancer</a><div class="gs_gray">G Begum, R Bryan, J Dunn, S Bathers, M Wallace</div><div class="gs_gray">European Urology Supplements 1 (1), 41<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:FAceZFleit8C" class="gsc_a_at">European Adjuvant Trials</a><div class="gs_gray">P Ghaneh, D Smith, J Almond, D Moffitt, J Dunn, J Slavin, R Sutton, ...</div><div class="gs_gray">Pancreatic Cancer, 255-267<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Six of the Best, Upper GI 14</a><div class="gs_gray">JP Neoptolemos, DD Stocken, JA Dunn, J Buckels, M Deakin, R Sutton, ...</div><div class="gs_gray">British Journal of Surgery 89 (S1), 35-35<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">tAnGo-A phase III, randomised trial of gemcitabine in paclitaxel-containing, epirubicin-based, adjuvant chemotherapy for higher risk, early stage, breast cancer</a><div class="gs_gray">CJ Poole, J Carmichael, RE Coleman, HM Earl, D Dodwell, M Verrill, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 85, 50-50<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:KUbvn5osdkgC" class="gsc_a_at">The use of a pre-trial questionnaire in determining recruitment intent in a study of sequencing of chemotherapy and radiotherapy in breast cancer</a><div class="gs_gray">S Bowden, I Fernando, J Dunn</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 85, 61-61<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LhH-TYMQEocC" class="gsc_a_at">European Study Group for Pancreatic Cancer-1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable&nbsp;…</a><div class="gs_gray">JP Neoptolemos, JA Dunn, DD Moffitt, J Almond, K Link, H Beger, C Bassi, ...</div><div class="gs_gray">Journal of British Surgery 88 (3), 475-475<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Hypothesis P53 mutation as basis for effect of paclitaxel-containing therapy on ER-negative tumours and of tamoxifen in obfuscating this in ER-positive in CALGB9344</a><div class="gs_gray">CJ Poole, HM Earl, M Verrill, P Canney, D Cameron, J Carmichael, ...</div><div class="gs_gray">European Journal of Cancer, 1-2<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Role of radiotherapy and duration of tamoxifen in early breast cancer (stage I): West Midlands Breast Group Prospective Randomised Collaborative Study (BR3002)</a><div class="gs_gray">D Spooner, JA Dunn, JM Morrison, GD Oates, DR Ellis, JR Lee, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 83, 2-2<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:TQgYirikUcIC" class="gsc_a_at">ESPAC-1 interim results: A European, randomised study to assess the roles of adjuvant chemotherapy (5 FU plus folinic acid) and adjuvant chemoradiation (40 Gy plus 5 FU) in&nbsp;…</a><div class="gs_gray">JP Neoptolemos, JA Dunn, DD Moffitt, J Almond, HG Beger, KH Link, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 83, 1-1<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Clinical cases</a><div class="gs_gray">AB Herod, J Buxton, J Tobias, D Luesley, S Jordan, J Dunn, CJ Poole, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:9pM33mqn1YgC" class="gsc_a_at">A Systematic Review of Factors Influencing the Accrual of Patients Into Cancer Trials (Including Reasons Why Clinicians Are Reluctant to Participate in National Multicentre Trials)</a><div class="gs_gray">LC Ward, GP Slegg, JA Dunn, P Harvey, MT Hallissey, C Hyde, G Begum, ...</div><div class="gs_gray">National Health Service<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Diagnostic delay, material deprivation and survival in bladder cancer</a><div class="gs_gray">DMA Wallace, S Bathers, G Begum, J Dunn</div><div class="gs_gray">Bju International-Supplement 83<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:c_xDhezhKKUC" class="gsc_a_at">CLINICAL ONCOLOGY-Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer</a><div class="gs_gray">MJS Langman, JA Dunn, JL Whiting, A Burton, MT Hallissey, ...</div><div class="gs_gray">British Journal of Cancer 81 (8), 1356-1362<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Oral clodronate reduces skeletal morbidity in multiple myeloma</a><div class="gs_gray">EV McCloskey, ICM MacLennan, MT Drayson, C Chapman, J Dunn, ...</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Pathological and immunohistochemical prognostic factors in clinical stage I breast cancer patients</a><div class="gs_gray">RA Walker, JA Dunn, PR Baker, P Stonelake, CM Jevons, JM Morrison, ...</div><div class="gs_gray">JOURNAL OF PATHOLOGY 186, 5A-5A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ALROH1vI_8AC" class="gsc_a_at">P01 Estimation in group sequential designs using simulated estimating equations</a><div class="gs_gray">M LeBlanc</div><div class="gs_gray">Controlled Clinical Trials 3 (18), S111<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">P12 The changing face of tamoxifen treatment and its influence on attom</a><div class="gs_gray">L Padmore, K Milligan, R Gray, J Dunn, MJR Lee</div><div class="gs_gray">Controlled Clinical Trials 3 (18), S117<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4vMrXwiscB8C" class="gsc_a_at">P02 An investigation of the effect of covariate adjustment in a sequential clinical trial</a><div class="gs_gray">M Sahdra, S Todd, J Dunn, TJ Priestman</div><div class="gs_gray">Controlled Clinical Trials 3 (18), S111-S112<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">P93 Establishing the ethics of randomization in breast cancer trials</a><div class="gs_gray">KR Abrams, JA Dunn</div><div class="gs_gray">Controlled Clinical Trials 3 (18), S168-S169<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:08ZZubdj9fEC" class="gsc_a_at">0-85. Role of radiotherapy in early breast cancer and the salvaging of patients with local relapse</a><div class="gs_gray">D Spooner, JM Morrison, GD Oates, DJ Ellis, MJR Lee, A Auckland, ...</div><div class="gs_gray">The Breast 4 (6), 248<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:OTTXONDVkokC" class="gsc_a_at">Screening for gastric cancer: is serology for Helicobacter pylori feasible?</a><div class="gs_gray">J Whiting, J Dunn, M Hallissey, J Fielding</div><div class="gs_gray">The British Journal of Surgery 83 (6)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Pancreatic Society of Great Britain and Ireland</a><div class="gs_gray">J DUNN, J MCCONKEYt</div><div class="gs_gray">Gut 36, A477-A480<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:evX43VCCuoAC" class="gsc_a_at">25. Oestrogen-regulated proteins and menstrual cycle in premenopausal breast cancer</a><div class="gs_gray">PS Stonelake, A Millard, K Ramsden, J Dunn, PR Baker, J Powell, ...</div><div class="gs_gray">The Breast 3 (4), 234<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Brussels moves Europe's Cinderella industry centre stage</a><div class="gs_gray">J Dunn</div><div class="gs_gray">Professional Engineering 7 (21), 7-8<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:bKqednn6t2AC" class="gsc_a_at">Immunohistochemical detection of the p53 gene-product in gastric-cancer patients-aberrant expression but no prognostic-significance</a><div class="gs_gray">J Linehan, S Jader, EE SANIDAS, IM FILIPE, J DUNN, D LEVISON</div><div class="gs_gray">Oncology reports 1 (6), 1263-1268<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BJrgspguQaEC" class="gsc_a_at">Seventeenth sir peter freyer memorial lecture and surgical symposium</a><div class="gs_gray">D O’Gradaigh, PJ Byrne, P Gillen, P Lawlor, TN Walsh, TPJ Hennessy, ...</div><div class="gs_gray">Irish Journal of Medical Science 163 (1), 68-92<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Pathogenesis of gall stones in Crohn's disease: an alternative explanation R Hutchinson</a><div class="gs_gray">PNM Tyrrell, D Kumar, JA Dunn, JKW Li, RN Allan</div><div class="gs_gray">Gut 35 (1), 94-97<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:4hFrxpcac9AC" class="gsc_a_at">P86 Evaluating the strength of prognostic factors in a series of 1400 patients with myelomatosis</a><div class="gs_gray">JA Dunn, I MacLennan</div><div class="gs_gray">Controlled Clinical Trials 14 (5), 464<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">P85 Cox regression versus discriminant techniques: Can we predict a high risk group in stage I epithelial ovarian cancer?</a><div class="gs_gray">JA Dunn, CB Finn</div><div class="gs_gray">Controlled Clinical Trials 14 (5), 463<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Influence of timing of surgery during menstrual, cycle on survival of premenopausal women with operable breast cancer</a><div class="gs_gray">PS Stonelake, J Powell, JA Dunn, J Warwick, SR Bramhall, ...</div><div class="gs_gray">The Breast 2 (3), 201-202<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors: The result of a retrospective study of 423 cases of uterine&nbsp;…</a><div class="gs_gray">KS Olah, JA Dunn, H Gee</div><div class="gs_gray">International Journal of Gynecology &amp; Obstetrics 40 (3), 274-274<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Urology II</a><div class="gs_gray">TH Lynch, B Waymont, JA Dunn, MA Hughes, DMA Wallace, LH Stewart, ...</div><div class="gs_gray">Irish Journal of Medical Science 161 (11), 32-33<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Problems in drawing conclusions in barrier contraceptive clinical trials with compliance problems</a><div class="gs_gray">IJ Sharma</div><div class="gs_gray">Controlled Clinical Trials 13 (5), 441<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Prognostic indices: Who needs them?</a><div class="gs_gray">JA Dunn</div><div class="gs_gray">Controlled Clinical Trials 13 (5), 381-382<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Comparing trials for the treatment of myelomatosis</a><div class="gs_gray">JA Dunn, I MacLennan</div><div class="gs_gray">Controlled Clinical Trials 13 (5), 441<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Developing a prognostic index for stomach cancer</a><div class="gs_gray">JA Dunn, MT Hallissey, BSC Group</div><div class="gs_gray">Controlled Clinical Trials 13 (5), 427<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Is Stage I Epithelial Ovarian Cancer Over-Treated Both Surgically and Systematically? Results of a Five-Year Cancer Registry Review</a><div class="gs_gray">CB FINN, DM LUESLEY, EJ BUXTON, GR BLACKLEDGE, K KELLY, ...</div><div class="gs_gray">Obstetrical &amp; Gynecological Survey 47 (7), 491-492<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:EkHepimYqZsC" class="gsc_a_at">The need for multivariate analysis: A survey of uterine sarcoma in the west Midlands health region</a><div class="gs_gray">JA Dunn, H Gee, K Kelly, K Olah, S Blunt, L Bromich, KK Chan</div><div class="gs_gray">Controlled Clinical Trials 12 (5), 687-688<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">STRENGTH OF ESOPHAGEAL CONTRACTIONS CAN BE CONTROLLED VOLUNTARILY</a><div class="gs_gray">RM VALORI, MT HALLISEY, JA DUNN</div><div class="gs_gray">GUT 30 (10), A1495-A1495<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">HYPERVENTILATION PROVOKES PAIN AND ALTERS ESOPHAGEAL MOTILITY IN PATIENTS WITH ANGINA-LIKE CHEST PAIN</a><div class="gs_gray">RM VALORI, E COLE, M LEMON, JA DUNN, R COCKEL</div><div class="gs_gray">GUT 30 (10), A1514-A1514<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:GtLg2Ama23sC" class="gsc_a_at">EVIDENCE THAT PROTEIN-KINASE-C MEDIATES ADHESION IN HUMAN MYELOMA CELLS</a><div class="gs_gray">JD LASKIN, JA DUNN, SM OCONNELL, DL LASKIN</div><div class="gs_gray">JOURNAL OF CELLULAR BIOCHEMISTRY, 201-201<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Imaging in head and neck cancer</a><div class="gs_gray">S Colley, D Gibson, H Mehanna, WL Wong, CC McConkey, JK Rahman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">ANALYSIS OF DNA DAMAGE PRODUCED BY AZIRIDINYLBENZOQUINONE (AZQ) AND FUNCTIONAL ANALOGS-CORRELATION TO CYTO-TOXICITY</a><div class="gs_gray">EJ TILCHEN, JA DUNN, R PAGE, RW TALLEY</div><div class="gs_gray">PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 25 (MAR), 329-329<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:SIv7DqKytYAC" class="gsc_a_at">THE PROTECTION OF ELECTRICAL POWER SYSTEMS-A CRITICAL REVIEW OF PRESENT-DAY PRACTICE AND RECENT PROGRESS-NORTH-WESTERN SUPPLY GROUP, AT MANCHESTER, 11TH DECEMBER, 1951-DISCUSSION</a><div class="gs_gray">EC SMITH, O HOWARTH, LC WALSHE, FE BROOKER, HG BONSON, ...</div><div class="gs_gray">PROCEEDINGS OF THE INSTITUTION OF ELECTRICAL ENGINEERS-LONDON 100 (73), 51-53<span class="gs_oph">, 1953</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1953</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">ELECTRICAL ENGINEERING PROBLEMS IN THE TROPICS-DISCUSSION</a><div class="gs_gray">EG WHITE, G BARNARD, LA WILLIAMS, SV MARKS, JF DUNN, ...</div><div class="gs_gray">PROCEEDINGS OF THE INSTITUTION OF ELECTRICAL ENGINEERS-LONDON 96 (52), 658-661<span class="gs_oph">, 1949</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1949</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">FACTORS INFLUENCING THE DESIGN OF HIGH-VOLTAGE AIR-BLAST CIRCUIT BREAKERS-NORTH-WESTERN CENTRE, AT MANCHESTER, 4TH JANUARY, 1949</a><div class="gs_gray">W KIDD, VA BROWN, JA PRESCOTT, JF DUNN, EM DAKIN, RG TORRY, ...</div><div class="gs_gray">PROCEEDINGS OF THE INSTITUTION OF ELECTRICAL ENGINEERS-LONDON 96 (52), 576-579<span class="gs_oph">, 1949</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1949</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">European Society for Medical Oncology Volume 14, No. 5 May 2003</a><div class="gs_gray">R Arriagada, J Gutiérrez, H Gogas, G Fountzilas, JP Neoptolemos, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:silx2ntsSuwC" class="gsc_a_at">23 PUBLIC REACTION TO IMPACT BASED WARNINGS DURING AN EXTREME HAIL EVENT IN ABILENE, TEXAS</a><div class="gs_gray">M Johnson, J Dunn, H Guerrero, S Lyons, L Myers, V Brown</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Leeds Institute of Health Sciences</a><div class="gs_gray">AF Smith, M Messenger, P Hall, C Hulme, AF Smith</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Value of information analysis of multiparameter tests for chemotherapy in early breast cancer</a><div class="gs_gray">PS Hall, A Smith, C Hulme, A Vargas-Palacios, A Makris, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:Ade32sEp0pkC" class="gsc_a_at">PET-NECK</a><div class="gs_gray">H Mehanna, CC McConkey, JK Rahman, WL Wong, AF Smith, C Nutting, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">JNCI 15-1086R1</a><div class="gs_gray">SE McCabe10, L Hughes-Davies12, A Makris13, RC Stein</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Original citation</a><div class="gs_gray">G Meardi, J Donaghey, D Dean</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Country: United Kingdom Group: West Midlands Breast Group (WMBG)</a><div class="gs_gray">J Dunn</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Professor James A McCaul1 (Corresponding author) Email: jim. mccaul@ me. com; Tel: 01274 383920</a><div class="gs_gray">MJA Cymerman, MS Hislop, MC McConkey, MJ McMahon, H Mehanna, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=ty1gkewAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=ty1gkewAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Oncology An International Cancer Journal</a><div class="gs_gray">PJ Hoskin, JW Denham, M Gospodarowicz, FD Patel, GCW Howard, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–509</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>